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ABSTRACT
Hepatocyte structural and functional integrity was characterised 
in rat and human short term monolayer cultures following 
isolation by a versatile biopsy perfusion technique.
A cryopreservation scheme was developed for rat hepatocytes which 
were established in subsequent monolayer culture. Cytochrome 
P450 activity did not appear to be inhibited following cryogenic 
storage, and survival of human hepatocytes following 
cryopreservation was broadly similar to that of rat hepatocytes. 
This is particularly encouraging in relation to maximising the 
use of available human liver tissue. It may allow establishment 
of a bank of cryopreserved human hepatocytes, taken from numerous 
individuals, to be used in short term cytotoxicity assays.
Cytotoxicity and perturbation of hepatocyte function involving 
measurement of a number of biochemical parameters was 
investigated following exposure to six chemicals (unknown at time 
of analysis). In general results were in agreement with reported 
in vivo data.
This study highlights the potential use of hepatocyte culture 
systems for investigation of specific cytotoxic events despite 
the well documented changes in cytochrome P450 activity. The 
potential incorporation of human tissue into such systems is also 
emphasised since human cytochrome P450 activity seems much more 
stable in culture.
Comparative analysis of xenobiotic metabolism and cytotoxicity 
data between cells isolated from laboratory animals and humans 
should allow a more critical evaluation of in vivo toxicological 
studies in laboratory animals. The use of human hepatocyte 
cultures should also put risk assessment in vivo on a more 
scientific basis.
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ABBREVIATIONS
ADP Adenosine Diphosphate
ATP Adenosine Triphosphate
DMSO Dimethylsulphoxide
ECOD Ethoxycoumarin-O-deethylase
EGTA Ethyleneglycol-bis-(B-aminoethylether) N - N ’ 
tetra-acetic acid
PCS Foetal calf serum
GSH Glutathione, reduced form
LDH Lactate dehydrogenase
NADH p Nicotinamide adenine dinucleotide, reduced 
form
NADPH p Nicotinamide adenine dinucleotide 
phosphate, reduced form.
NaOH Sodium hydroxide
PBS 'A ' Calcium and magnesium free phosphate buffered 
saline
PCA Perchloric acid
TCA Trichloroacetic acid
TPB Tryptose phosphate broth
Tris Tris (hydroxymethyl) amino methane
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INTRODUCTION
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General Introduction
The mammalian liver is an important organ in toxicological 
studies as it is a common site of damage elicited by many 
naturally occuring and synthetic chemicals. This vulnerability is 
related to the position, structure and biochemistry of the liver. 
The oral route is the main portal of entry into the body for many 
chemicals, and the liver is the first major organ to receive any 
substance following absorption from the gastrointestinal tract.
The liver also has an extensive role in intermediary metabolism 
which offers numerous potential target sites for attack by 
reactive chemicals. Furthermore, the liver is the primary organ 
in the body for the metabolism of foreign compounds which, in 
general, is a detoxification procedure but in certain cases may 
lead to an increase in toxicity.
The toxicological implications of these activated metabolites may 
occur either in the liver or in extra-hepatic tissues, 
consequently the involvement of metabolic activation in cellular 
injury is of considerable interest. Although a few hepatotoxic 
agents, such as carbon tetrachloride, ethanol and paracetamol 
have been studied in detail, little is proven of the mechanisms 
by which such chemicals cause cell death. It is hoped that 
studies on mechanisms of hepatotoxicity will not only lead to an 
explanation of the observed manifestations associated with 
chemical mediated liver necrosis but will also provide a suitable 
model for toxicity studies using other tissues.
Isolated mammalian cells offer a suitable experimental model to 
study mechanisms of chemical induced toxicity away from the 
complexity of the intact body and interference from various 
physiological factors. Therefore, mechanisms of hepatotoxicity 
are best investigated in freshly isolated liver cell systems 
which maintain differentiated structural and functional 
characteristics similar to those observed in vivo.
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The mammalian liver contains a wide variety of cell types but the 
hepatocytes, which are predominant and also responsible for most 
xenobiotic metabolism, are the cell type in which a toxic 
response is usually elicited. Hepatocytes from experimental 
animals, particularly the rat, have been extensively used in the 
last few years to investigate chemical induced hepatotoxicity. 
However, results cannot reliably be related to man because of the 
known species difference in both liver biotransformation of 
chemicals and response to toxic insult; consequently adult human 
hepatocytes offer a more relevant model system to man.
The Liver as a Target Organ for Toxicity
The liver is exposed to many potentially toxic substances and is 
frequently a target organ in experimental animals. Although a 
diverse range of chemicals are known to be hepatotoxic in man 
(Timbrell 1986) the incidence of liver damage appears to be less 
common; only 10% of reported adverse drug reactions involve the 
liver (Davis 1982). However, the case fatality rate is often 
high, the severity of hepatic injury being such that 
drugs are a major cause of hepatic failure (Timbrell 1983).
Basic Structure of the Liver
The liver is the largest organ in the body and is served by two 
blood supplies; the portal vein and hepatic artery. The portal 
vein carries blood from the capillaries draining the 
gastro-intestinal tract, spleen and pancreas while the hepatic 
artery supplies oxygenated blood. After passage through the 
liver blood drains via the hepatic vein into the inferior vena 
cava. Incoming and outgoing blood are separated by the sinusoids 
which are in intimate contact with the hepatic parenchymal cells. 
The branches of the portal and hepatic veins do not meet but 
interdigitate around the structural/functional units (hepatic 
lobules) which comprise the liver.
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The lobule is a functional as well as structural concept and may 
be described in three ways; classical, portal and hepatic acinus 
(Jones & Spring-Milies 1977). The classical lobule describes a 
hexagonal section of tissue with portal tracts as boundaries and 
the hepatic vein at the centre, emphasizing the endocrine 
function of the liver. The portal lobule is a triangular 
arrangement around the portal tracts with a central vein at each 
corner which emphasizes the secretion of bile towards the centre. 
The simple liver acinus, as described by Rappaport (1979a), is 
the most recent and, probably, the most useful concept 
toxicologically (Fig 1).
The hepatic acinus is bounded by two or more portal tracts and 
two terminal central veins. Parenchymal cells are arranged in 
plates, one or two cells deep, separated by sinusoids and 
arranged into lobules. Blood flows from the centre to the 
periphery (central vein), bile flow being in the opposite 
direction towards the bilary ductules within the portal tracts. 
This concept emphasizes the existence of a microcirulatory 
hepatic unit and a metabolic gradient within the acinus, three 
zones being distinguished by their distance from the terminal 
vascular branch (Fig 1). Zone 1 receives blood that is still 
rich in nutrients and oxygen whilst cells in zone 3 receive blood 
that is poor in oxygen; zone 2 is a transition zone.
Metabolic heterogeneity is evident within the liver. Hepatocyte 
functional activity depends on the specific position within the 
hepatic acinus and is related to hepatic blood flow. Hepatocytes 
in different areas of the liver exhibit differences in 
subcellular structure and metabolic activity (Jungermann 1986) 
which may account for the observed localisation of toxic lesions 
following exposure to certain chemicals.
Cells in zone 1, periportal hepatocytes, are particularly well 
equipped for the tricarboxylic acid cycle, gluconeogenesis, 
protein synthesis, amino acid catabolism and fatty acid p 
oxidation, and they are less sensitive to cellular injury
— A —
Fig 1 Schematic Representation of a Hepatic 
Acinus
ev
PTPT
PT cv
PT - portal tract consisting of branches of the 
portal vein, hepatic artery and bile duct.
CV - branch of the central vein.
(From Rappaport 1979a)
(Rappaport 1979b). Zone 3, perivenous hepatocytes, have a 
greater amount of smooth endoplasmic reticulum, an associated 
higher cytochrome P450 monooxygenase activity, and are more 
sensitive to cellular damage. Cellular protective mechanisms and 
detoxification pathways, such as glutathione content, 
glutathione peroxidase and UDP-glucuronosyl transferase, are 
predominant in Zone 1.
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Although direct damage to hepatocytes leading to cellular 
necrosis is probably the most common form of liver injury the 
mammalian liver contains a range of different cell types which 
may be the target for certain compounds (Fry and Bridges 1979).
Mechanisms of Toxic Liver Injury
The nature of damage sustained by the liver reflects its 
structure and function; liver injury appears to involve either 
a perturbation of hepatocyte metabolic function or of the 
synthesis and secretion of bile. Liver injury may follow acute 
intoxication as in the case of paracetamol and carbon 
tetrachloride (Recknagel & Glende 1973, Mitchell et al 1973) or 
following chronic exposure, such as in thioacetamide intoxication 
(Gupta 1956). Cell necrosis may be evident throughout the liver 
or localised, as in centrilobular necrosis following exposure to 
bromobenzene (Jollow et al 1974). Cholestatic damage may occur 
from interference with bilirubin transport, as in the case of 
rifampicin (Capelle et al 1972), or from bile duct damage such as 
that which occurs following exposure to chlorpromazine (Zimmerman 
1978).
Liver necrosis is an advanced and usually irreversible stage of 
tissue degeneration and present knowledge of the mechanisms 
involved in cell death is incomplete. The nature and severity of 
cell injury depends on a number of factors including the extent 
to which the biological function of target sites(s) are modified, 
duration of the effect, the importance of the altered function(s) 
in relation to short or long term cell survival, and the ability 
of various cellular mechanisms to repair, replace or compensate 
for the modified function(s) (Bridges et al 1983).
Early changes observed following a toxic insult involve damage to 
various organelles, such as mitochondria and endoplasmic 
reticulum, which becomes progressively more extensive. 
Proliferation of certain organelles involving either
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mitochondria, peroxisomes or endoplasmic reticulum, may also 
occur following exposure to certain compounds. However, whilst 
most cells appear to recover from early chemical induced cellular 
changes, it is difficult to clarify the existence of certain 
early, critical events which determine whether cell death ensues.
A number of general biochemical mechanisms associated with liver 
damage have been postulated, based on the assumption that cell 
injury is initiated at certain key target sites(s); one or more 
of which may be responsible for subsequent cell necrosis 
following a chemical insult. Various biochemical mechanisms 
believed to be involved include:
a) Inhibition or induction of cellular enzyme activity
b) Membrane associated disturbance
c) Covalent binding
d) Protein synthesis
e) Cofactor levels
a) Inhibition or Induction of Cellular Enzyme ,Activity:
Certain chemicals are known to induce toxicity following specific 
enzyme inhibition such as parathion inhibition of cholinesterase 
(Cage 1953) and dinitrophenol uncoupling of oxidative 
phosphorylation (Cunningham et al 1986). Hepatotoxicity due to a 
direct effect on an enzyme without prior metabolism and not 
involving coenzyme depletion or membrane disturbance is unusual 
(Cheeseman 1984). Many chemicals which may be non-toxic per se 
can be extremely important in modifying the hepatotoxicity of 
other compounds by their influence on liver drug metabolising 
enzymes.
b) Membrane Associated Disturbances:
Normal liver function depends on the integrity of various 
cellular membranes. A sensitive assay of impaired liver function 
in vivo involves the appearance of increased levels of certain 
liver enzymes in blood following a toxic insult. This may 
reflect a direct action of a toxin on the plasma membrane or be a
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consequence of a severely disrupted cellular metabolic function.
A variety of chemicals are known to exert a direct action on the 
plasma membrane causing a modification of specific transport 
sites, as in the; case of amino acid transport systems (Goethals 
et al 1983). Some chemicals produce general changes in membrane 
components leading to an alteration of associated functions; 
thioacetamide is reported to alter phospholipid fatty acid 
composition of the mitochondrial inner membrane (Moller & Dargel 
1984). Changes in membrane permeability may also disturb 
critical organelle/cytosol ion gradients which may influence a 
variety of cellular processs, as in the case of the influence of 
cellular Ca^^ levels on phospholipase activity and microtubule 
organisation. Another non-specific membrane disturbance involves 
peroxidative attack on unsaturated fatty acids which are 
essential for normal membrane function. Lipid peroxidation is 
reported to be associated with liver necrosis following 
intoxication by various chemicals such as carbon tetrachloride 
(Slater 1978) and paracetamol (Wendel et al 1979). However, it 
remains to be established if lipid peroxidation is the cause or 
consequence of cellular necrosis.
c) Covalent Binding:
Recently, it has become increasingly clear that hepatic 
xenobiotic metabolism in vivo may yield reactive metabolites 
capable of covalently binding to cellular macromolecules; the 
degree of binding depending on the chemical reactivity of the 
activated metabolite. Covalent binding is not thought to be the 
primary cause of cell death although it appears intimately 
related to it, the extent of covalent binding correlating with 
the severity of cellular necrosis for a number of hepatotoxic 
agents, such as bromobenzene and paracetamol (Mitchell et al 
1973; Hinson et al 1981; Brodie et al 1971). However, a 
correlation between covalent binding and cell death is frequently 
not straightforward as it is likely that the majority of cellular 
proteins that are associated with covalently bound residues are 
not essential for short term cell survival. The value of 
covalent binding studies is rather limited since it is difficult
to interpret the toxicological significance of results, although 
it is a useful indicator of the formation of chemically reactive 
metabolites (Bridges et al 1982).
d) Protein Synthesis:
Inhibition of protein synthesis is a commonly observed phenomenon 
associated with in vivo hepatotoxicity (Sweeney 1981), 
nevertheless, discrepancies often exist between inhibition of ' 
protein synthesis and the onset of liver necrosis. Impairment 
normally occurs rapidly, indicative of a direct action, but 
inhibition of protein synthesis does not appear to be a primary 
factor in initiating cell death although it may contribute if 
cellular repair processes become critical factors in cell 
survival. Inhibition of protein synthesis may occur at various 
stages, including membrane transport of amino acids, or at 
translational or transcriptional stages. '
e) Cofactor levels:
Certain hepatotoxins disturb liver metabolism as a result of 
their ability to rapidly deplete or cause a build up of an 
essential co-enzyme or metabolite. The antibiotic azaserine 
rapidly depletes hepatic NAD and NADH levels with far reaching 
consequences for numerous biochemical functions (Cheeseman 1984). 
Rapid depletion of cellular NAD? and NADPH is associated with 
carbon tetrachloride intoxication (Slater 1978).
Cellular ATP levels also appear vulnerable following exposure to 
various chemicals; ethionine and dinitrophenol both cause a large 
and swift decrease in hepatic ATP levels in the rat (Villa- 
Trevino et al 1964, Cunningham et al 1986). This can have 
numerous consequences as adequate levels of ATP are essential for 
a range of transport, repair and synthetic processes. A decrease 
in cellular ATP may occur following inhibition of reduced 
cofactor synthesis, depletion of reduced cofactor levels, 
inhibition of oxidative phosphorylation, or an enhanced ATP 
hydrolysing activity.
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The tripeptide glutathione is intimately associated with 
maintenance of cellular integrity. It participates in important
detoxification reactions (Moldeus & Jernstrom 1983) and the ratio
of reduced to oxidised glutathione is critical in regulating 
protein and enzyme functions, protein synthesis and the
maintenance of cellular redox states (Kaplowitz 1981). Depletion
of cellular glutathione levels is associated with the severity of 
hepatic necrosis following paracetamol (Mitchell et al 1985) and 
bromobenzene intoxication (Gillette et al 1974), possibly by 
permitting reactive metabolites to covalently bind to cellular 
macromolecules in increasing amounts.
The relative importance of early molecular changes involved in 
hepatotoxicity appears to vary from chemical to chemical and 
subsequent cell death seems to occur only when cellular 
protective mechanisms are overwhelmed by several toxic changes. 
However, it remains unclear whether a common sequence of events 
preceeds cell death.
Influence of Metabolic Activation on Toxic Liver Injury
Many types of toxicity including carcinogenesis and mutagenesis 
are known to be mediated by reactive metabolites resulting from 
the metabolism of xenobiotics to reactive electrophiles which 
covalently bind to critical cell molecules including DNA, RNA, 
and proteins (Jollow et al 1974, Miller 1978). The enzyme system 
primarily involved in the production of active metabolites is the 
cytochrome P450 dependant mixed function oxidase system of the 
endoplasmic recticulum although other enzyme systems, such as the 
microsomal flavoprotein enzymes, cytosolic alcohol and aldehyde 
dehydrogenases may be important in certain instances (Fry 1982a). 
These phase 1 reactions are generally followed by one of a number 
of biosynthetic conjugation reactions, the overall
biotransformation process normally being a detoxification process 
although conjugation may also result in a more toxic species.
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Routes of metabolic activation invariably occur alongside other 
competing inactivation pathways, consequently the balance of the 
activities of these pathways will ultimately determine the rate 
and extent of formation of the active metabolite(s ) . Various 
factors which influence the activity of these enzyme systems will 
have a profound effect on subsequent toxicity. Many chemicals, 
including paracetamol and bromobenzene, which require metabolic 
activation for expression of toxicity are known to cause 
centrilobular necrosis. This, presumably, reflects the higher 
cytochrome P450 activity and lower cellular protective mechanisms 
in this region of the liver (Cheeseman 1984).
Metabolic activation may also involve free radical formation 
which has important toxicological consequences. This may involve 
either recycling reactions that may deplete reduced cofactor 
levels or initiation of chain reactions, for example, those which 
occur in lipid peroxidation. Free radical formation may result 
from a direct conversion of a chemical to a free radical species, 
as in the case of carbon tetrachloride (Cheeseman 1984), or 
through a byproduct of xenobiotic metabolism. Thus, 
biotransformation of xenobiotics may play a major role in 
determining the extent of toxicity elicited by many chemicals.
The Role of In Vitro Toxicology Studies
There are considerable ethical and financial pressures to reduce 
the numbers of animals used in toxicity testing of existing and 
new chemicals (Nardone 1977, Balls & Clothier 1983). Isolated 
mammalian cell systems offer a suitable experimental model to 
study specific toxic properties of chemicals and to investigate 
mechanisms of chemical mediated toxicity away from the complexity 
of the intact body and interference from various physiological 
factors (Bridges et al 1982, Dawson 1982). The use of in vitro 
systems may contribute greatly to a more scientific approach to 
toxicity testing and enable the scientist to make a more critical 
reappraisal of existing in vivo procedures.
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Intact cell systems also have the potential advantage of 
reflecting the in vivo balance of activation and inactivation 
processes whilst retaining critical metabolic functions which are 
essential requirements for the use of such systems in toxicity 
testing (Grisham et al 1978). One particular advantage of an in 
vitro approach is the possibility of incorporating human material 
thus eliminating the problems inherent in extrapolating data 
obtained in experimental animals.
Hepatocyte Preparation Techniques
Liver tissue was first cultured in vitro 70 years ago but 
selective culture of the different types of hepatic cells has 
occured only within the past 18 years. This accomplishment was 
achieved by Berry and Friend (1969) who developed a two step in 
situ collagenase perfusion to prepare suspensions of viable 
hepatocytes from an intact rat liver. A number of modifications 
to the original technique exist, the influence of which is 
extensively reviewed by Seglen (1976a). This perfusion technique 
is now widely used for obtaining viable dispersed hepatocytes 
from numerous species (Maslanski & Williams 1982). Isolated 
adult hepatocyte suspensions are a heterogenous cell population 
in terms of degree of ploidy and functional activities; various 
methods exist for the separation of these different hepatocyte 
sub-classes (Bernaert et al 1979; Gumucio et al 1986).
Initial attempts to adapt the two step in situ collagenase 
perfusion to human liver were largely unsuccessful; this was 
mainly due to difficulties imposed by the size of the intact 
organ and the additional problem of obtaining suitable healthy 
samples. As a result, early published research involved explant 
culture of human liver samples which consisted mainly of 
undifferentiated epithelial cells (Guillouzo et al 1972; Demoise 
et al 1971; Sandstrom 1973; Lemonnier et al 1976). Non-perfusion 
techniques involving dissociation of human liver samples by 
mechanical disruption and subsequent enzymatic digestion result
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in fairly low yields of viable hepatocytes (Maekubo et al 1982; 
Miyazaki et al 1981).
Recently developed perfusion techniques allow the isolation of 
large numbers of viable adult human hepatocytes by perfusion of 
either a portion of the whole liver (Guguen-Guillouzo et al 
1982a; Hsu et al 1985) or perfusion of a biopsy (Reese & Byard 
1981; Strom et al 1982; Ballet et al 1984). Human liver samples 
are usually obtained from kidney donors who have received little 
or no prior medication or from patients undergoing partial 
hepatectomy. Viability and functional integrity of isolated rat 
hepatocytes prepared by biopsy perfusion are similar to that of 
hepatocytes prepared by whole liver perfusion (Green et al 1983). 
Isolation of rat and human foetal hepatocytes is also feasible 
(Liddiard et al 1980; Guguen-Guillouzo et al 1980).
Storage of Liver Tissue and Isolated Hepatocytes
Adult human liver samples are infrequently available and simple, 
effective methods of storing either tissue or isolated 
hepatocytes would be immensely valuable in the present 
circumstances, especially since samples often become available at 
inconvenient times.
Literature concerning storage of liver tissue prior to hepatocyte 
isolation is scarce, although either ice-cold saline or culture 
medium are a suitable transport medium for samples perfused 
within one hour of surgical resection (Ballet et al 1984, Strom 
et al 1982).
Storage of other human tissues is possible - human bronchi can 
survive storage in L 15 medium for several days at room 
temperature (Trump et al 1980) and for up to one week at 4°C 
(Barrett et al 1976) - prior to establishing explant cultures. 
Explant cultures can also be established from human colonic 
tissue stored in L15 medium at 4°C for up to 24 hours (Autrup
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1980), from human peripheral lung after 4 hours (Stoner 1980), 
and from human mammary epithelium after 4 days (Hillman et al
1983). A simple cryogenic storage method may be used to store 
human skin biopsies without loss of fibroblastic cell growth 
(Fowler 1984). However, little indication of retention of 
differentiated cell function is given in these studies.
Cryogenic storage of hepatocytes without loss of specific 
functions would be extremely valuable in a number of research 
areas including the in vitro study of xenobiotic metabolism, - 
carcinogenesis, mechanisms of chemical induced toxicity and 
hepatic disease.
Success involving cryopreservation of hepatocytes is limited and 
there is conflict between reports of optimal freezing conditions, 
particularly with reference to cooling rates. A rapid cooling 
regime (Gomez et al 1984) and a slow cooling regime (Le Cam et al 
1976) have each been reported to be optimal, other research 
groups apparently tending to arbitrarily employ a slow cooling 
rate in the region of 1°C per minute (Jackson et al 1985; 
Coundouris et al 1986). Certain studies indicate that viability 
and drug metabolising efficiency of freshly thawed hepatocytes 
are similar to that of freshly prepared cells (Novicki et at 
1982; Fuller & DeLoecker 1980). Other studies, however, point to 
an impaired hepatocyte metabolic capacity (Fuller & James 1985; 
Nutt et al 1980; Le Cam et al 1976) following a slow cooling 
regime but not following a rapid cooling regime (Gomez et al
1984).
Numerous structurally unrelated chemicals are known to exert a 
cryoprotective effect on mammaliam cells, a synergistic action 
having been observed between various cryoprotective agents (Klebe 
& Mancusso 1983). Many conflicting theories exist to explain 
cellular injury resulting from cryopreservation, few of which 
stand on solid ground. One phenomenon generally applicable to 
many biological systems is that rapid and slow cooling rates 
damage cells but an intermediate rate of cooling often exists
14 -
which allows some cell survival (Farrant & Ashwood-Smith 1980). 
Further research is warranted to identify those factors critical 
for cell survival in order to develop a successful 
cryopreservation scheme which will allow storage of hepatocytes 
without loss of differentiated function.
Biochemical Characteristics of Primary Hepatocyte Monolayer 
Cultures
Rat hepatocytes are used extensively to investigate hepatocyte 
biochemical function, the functional capacities of freshly 
isolated hepatocytes closely resembling those of in vivo 
hepatocytes. A number of criteria - such as ATP content and LDH 
leakage (Cornell 1982) - have been proposed as indicators of 
isolated hepatocyte viability and metabolic integrity although 
no single criterion can be regarded as ideal. The trypan blue 
exclusion test is commonly employed but a well defined refractive 
shape can usually be regarded as indicative of a viable healthy 
cell. Hepatocyte survival time in suspension culture is 
effectively limited to around 4 hours which restricts their use : 
in toxicological studies; isolated hepatocytes also exhibit an 
impaired response to hormones and alterations in the plasma 
membrane.
There is considerable evidence to suggest that a wide range of 
specialised hepatocyte functions are expressed in short term 
monolayer culture. However, hepatocytes under classical cell 
culture conditions are unable to retain a stable differentiated 
state and a decline in specific functions is apparent after a few 
days in culture (Bissell et al 1973, Guguen-Guillouzo & Guillouzo 
1983). Various liver specific enzymes exhibit a dramatic 
decrease in activity including pyruvate kinase, aldolase, 
tyrosine aminotransferase and glucokinase. Predominant 
isoenzymic forms that are present exclusively in adult 
hepatocytes, as in the case of pyruvate kinase, gradually 
decrease in culture and minor forms normally associated with
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fetal hepatocytes appear to be the only forms detectable after a 
few days. The loss of adult associated isozymes suggests that 
adaptation to culture leads to a shift towards a more fetal-like 
state (Guguen-Guillouzo 1983). Various hormones such as insulin 
and, in particular, glucocorticoids markedly improve hepatocyte 
survival in culture although the mechanism of action is poorly 
understood and loss of specific functions is still evident 
(Miyazaki et al 1985; Nakamura & Ichihara 1985; Wirthensohn & 
Barth 1985).
Gluconeogenic activity in primary hepatocyte cultures was first 
demonstrated by Bissell et al (1973) and its control and 
regulation recently discussed by Hue and Girard (1986). The 
activity of glucose-6-phosphate dehydrogenase, a key rate 
limiting enzyme in the pentose phosphate pathway, is modulated in 
hepatocyte cultures by insulin and glucocorticoids (Fritz et al 
1986). Metabolic zonation exhibited in vivo is also apparent in 
hepatocyte cultures, gluconeogenesis and urea synthesis being 
higher in periportal hepatocyte cultures than in perivenous 
cultures under identical culture conditions in the absence of 
hormones (Quirstorff et al 1986).
Hepatocyte monolayer cultures also continue to synthesise and 
secrete various plasma proteins including albumin and transferrin 
(Guillouzo 1986), glycoproteins such as fibronectin and laminin 
(Diegelmann 1986), and various types of collagen. Nevertheless, 
activities tend to decrease rapidly after a few days in culture 
although urea production is ostensibly well maintained over 
several days. Synthesis and secretion of various lipoproteins is 
modulated by insulin (Patsch et al 1986) and protein synthesis in 
culture is enhanced by hydrocortisone (Silove & Hattingh 1986).
The induction or modulation of certain enzyme activities - such 
as alanine aminotransferase, tyrosine aminotransferase, 
phosphoenolpyruvate carboxykinase and glucose-6 -phosphate 
dehydrogenase - is generally regarded as indicative of an 
expression of a differentiated state. Although the mechanisms
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involved are not properly understood, the influence of hormones 
on key enzyme activities such as pyruvate kinase may be mediated 
by protein kinase phosphatase enzymes (Lopez-Alarcon et al 1986). 
The effect of various hormones on specific hepatocyte functions 
is also reflected by the composition and ultrastructural 
organisation of cytoskeletal elements and many cytokeratins may 
be useful as markers of a differentiated state (Marceau et al 
1986). Response to hormones like insulin also depends upon cell 
density (Ichihara et al 1986) which highlights the critical role 
played by cell communication in maintaining a stable 
differentiated state and possibly reflects in vivo specialised 
contacts between adjacent cells (Bissell 1982).
Recent developments indicate that retention of a more stable 
differentiated state may be possible following co-culture of 
hepatocytes in the presence of other liver cell types. These 
include an uncharacterised, partially transformed cell line 
(Guguen-Guillouzo et al 1983) or liver sinusoidal cells (Morin & 
Normand 1986) but not cell types such as fibroblasts 
(Michalopoulos et al 1979). Initial studies indicate a dramatic 
retention of the few hepatocyte specific functions examined, 
albumin synthesis, cytochrome P450 content and tyrosine amino­
transferase activity.
Hepatocyte survival also appears to be promoted by a number of 
factors including collagen substratum (Reid & Jefferson 1984)
- a specifically designed hepatocyte serum free hormonally 
defined medium in conjunction with an extracellular matrix (Reid 
et al 1986) - and by supplementation of medium with DMSO (Isom et 
al 1985) or phénobarbital (Miyazaki et al 1985). The mechanisms 
involved are not, as yet, comprehensively understood and there 
remains the question of the existence of one common mechanism; 
results tend to vary greatly between laboratories. However, 
these advances in retention of specific hepatocyte functions 
augment well for the future study of mechanisms of chemical 
mediated toxicity in hepatocyte monolayer cultures with regard to
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identifying the molecular target sites of action for various 
hepatotoxins.
Adult human hepatocytes can be maintained in short term monolayer 
culture but phenotypic changes, including loss of specific 
hepatocyte functions, also occur after a few days. Nevertheless, 
human hepatocytes appear to adapt better to culture than rodent 
hepatocytes as protein synthesis and cytochrome P450 levels 
appear more stable under classical culture conditions (Clement et 
al 1984). In a co-culture system adult human hepatocytes appear 
to express high levels of certain specific functions (Guguen- 
Guillouzo et al 1982b).
Drug Metabolism in Primary Hepatocyte Monolayer Cultures
Isolated hepatocytes are a valuable model for the study of drug 
metabolism since they retain the ability to carry out a wide 
range of phase I and phase II routes of xenobiotic metabolism.
The overall metabolism of xenobiotics in isolated hepatocytes 
closely resembles that observed in vivo as the levels of 
cytochrome P450 and various conjugation enzymes are similar to in 
vivo levels. Drug metabolism in isolated hepatocytes is 
intimately related to factors that influence metabolising 
activity in vivo prior to isolation and reflects both incubation 
conditions and the relative stability of a number of isoenzymic 
forms. Drug metabolism hetereogeneity within the lobule also 
appears to be retained after hepatocyte isolation (Gumucio et al 
1986).
A rapid decrease in cytochrome P450 content occurs during the 
first 24 hours of culture so that only between 10% and 40% of 
initial levels remain (Fry & Bridges 1979; Guzelian et al 1977). 
The mechanisms involved are largely unknown although loss of 
cytochrome P450 can be temporarily delayed by supplementation of 
the medium with various hormones (Decad et al 1977), ligands and 
haem precusors. Changes in cytochrome P450 content appear to
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result from alterations in degradation and/or synthesis rates of 
haem and/or apoprotein (Paine & Villa 1980). Substituted 
pyridines seem to maintain pre-existing cytochrome P450 levels by 
ligand formation with the cytochrome reducing its rate of 
turnover (Paine et al 1980), and precursors of haem synthesis 
such as 5 aminolaevulinic acid also appear to delay the rate of 
decrease (Paine & Hockin 1980).
However, besides a general decrease in cytochrome P450 levels, 
monooxygenase activities also decline to different extents in 
culture resulting in a change in the main type of cytochrome P450 
present (Fry et al 1980). These changes suggest a differential 
in vitro stability of cytochrome P450 subspecies (Guzelian et al 
1977; Guengerich 1984) possibly reflecting differences in either 
synthesis and/or degradation rates. Consequently, the spectrum 
of cytochrome P450 subspecies induced by various chemicals may 
differ from those induced in vivo (Lake & Paine 1982; Englemann 
et al 1985) which may also involve differences in degradation 
rates (Schuetz et al 1986). Commercially available culture media 
appear to differ markedly in their ability to maintain cytochrome 
P450 levels (Grant et al 1985), and a species difference is also 
apparent with in vitro stability of cytochrome P450 (Maslanski & 
Williams 1 982).
Recent research indicates a retention of cytochrome P450 levels 
for several days in hepatocytes maintained in a co-culture system 
(Begue et al 1984) although it is not clear if this reflects the 
full spectrum of cytochrome P450 subspecies observed in vivo.
The overall metabolism of chemicals is an important factor in the 
use of hepatocyte cultures in pharmacotoxicological studies. 
However, much less is known about conjugation enzyme activities 
with sulphate, glucuronic acid and glutathione. Initial studies 
indicate that glucuronosyl transferase and glutathione 
transferase activities may be maintained for several days in rat 
hepatocyte cultures (Suolinna et al 1986).
Procedures for isolation of human hepatocytes are a recent
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development thus studies involving drug metabolism are still very 
limited. Monooxygenase activity and subsequent conjugation of 
metabolites with sulphate and glucuronic acid in freshly isolated 
human hepatocytes has been reported by Tee et al (1985).
In conventional monolayer culture, human hepatocyte cytochrome 
P450 levels appear to be more stable than their rodent 
counterparts (Grant et al 1986c), although a 50% decrease still 
occurs during the first week in culture (Guillouzo et al 1985b). 
This greater stability is also reflected by the maintainance of 
two major cytochrome P450 subspecies in human hepatocyte cultures 
(Ratanasvanh et al 1986) and by the biotransformation of 
ketotifen (Begue et al 1983). This drug undergoes various 
metabolic pathways in man and is metabolised in adult human 
hepatocyte cultures according to the pathways normally found in 
vivo - including déméthylation, oxidation, reduction and 
glucuronidation - which remain active for several days.
Retention of glucuronyItransferase activity (Belleman et al 1979) 
and conjugation with glutathione in human hepatocyte cultures 
(Grant et al 1986c; Vandenberghe et al 1986) suggests 
that human hepatocytes adapt better to culture and, unlike rat 
hepatocytes, do not appear to exhibit a shift towards a fetal- 
like state. Aldehyde dehydrogenase activity, an enzyme with a 
wide subcellular distribution, is maintained to a greater extent 
in human hepatocyte cultures (Marcelos et al 1986) which also 
indicates a more stable differentiated state.
The use of adult human hepatocytes in pharmacotoxicological 
studies should take into consideration various factors which may 
influence a response in isolated or cultured cells. Trauma to 
kidney donors or drug administration in vivo before organ 
resection may influence subsequent drug metabolism in hepatocyte 
monolayer cultures (Guillouzo 1986). Other contributing factors 
include inter-individual variation in drug metabolising capacity; 
a 2-5 fold inter-individual variation in monooxygenase activity 
having been observed for three different substrates in adult 
human hepatocyte suspensions (Seddon et al 1986). A marked
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inter-individual variation was also exhibited in metabolism of 
2AAF (Smith & Chipman 1986).
Suspension and monolayer cultures of human fetal hepatocytes 
retain monooxygenase activity (Nau et al 1978; Pelkonen et al 
1975; Guillouzo et al 1972) but activity is lower than that of 
adult human hepatocytes. This also applies to conjugation 
activity with glucuronic acid which .is markedly lower. Although 
the use of such cells is of relevance to the drug metabolising 
capacity of the fetus they do not represent an appropriate model 
to the adult in vivo situation.
The Use of Hepatocytes in Toxicity Studies
Isolated hepatocytes are widely used as an experimental model for
toxicity assessment (Fry & Bridges 1979; Inmon et al 1981;
Gottschall et al 1983; Vonen & Moorland 1984) and may serve as a 
simple screening system to identify potential hepatotoxic agents. 
Parameters employed to evaluate cytotoxicity in these systems, 
such as dye uptake and enzyme release, are rather gross indices 
of toxicity. However, some authors emphasize the importance of 
cellular metabolic competence as a sensitive indicator of 
hepatocyte injury. Various parameters have been employed as 
indicators of early cell injury (Table 1).
Hepatocytes are also employed to study the involvement of 
xenobiotic metabolism in cytotoxicity (Fry 1982b; Bates et al 
1981; Thor et al 1979). Species differences in xenobiotic
metabolism in the intact animal also appear to be reflected to a
similar extent in isolated hepatocytes (Holme & Soderlund 1986; 
Moldeus 1978). However, the limited experimental time of 
hepatocyte suspensions restricts their use in 
pharmacotoxicological studies.
Primary hepatocyte cultures retain some xenobiotic metabolising 
capacity, making them potentially useful for studying mechanisms
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of chemical induced toxicity. However, one major limitation is 
the quantitative and qualitative changes occuring in drug 
metabolising enzyme activities. Another associated problem 
involves the fate of potentially toxic substances upon prolonged 
incubation of cultures and their possible accumulation in the 
medium.
Table 1 Parameters Indicative of Early Cell Injury
Parameter Test Chemical Reference
protein synthesis PAR Krack et al (1983)
glycogen synthesis PAR Krack et al (1983)
protein synthesis BrB Goethals et al (1984)
protein synthesis BrB Thor et al (1979)
protein synthesis DEM Goethals et al (1983)
glutathione cont ent PAR Moldeus & Jernstrom 
(1983)
glutathione cont ent BrB Thor et al (1978)
glutathione content PAR Mitchell et al (1985)
glutathione cont ent EDB Albano et al (1984)
glutathi one content BrB Casini et al (1982)
glutathione cont ent PAR Hayes et al (1986)
NADPH levels BrB Thor et al (1980)
ATP levels PAR Gwynn (1981)
ATP levels BrB Thor et al (1980)
ATP levels Cd2+ Muller et al (1984)
ATP levels DNP George et al (1982)
PAR - paracetamol, BrB - bromobenzene, DEM - diethylmaleate, 
EDB - ethylene dibromide, DNP - dinitrophenol, Cd^+ - cadmium.
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Enzyme leakage occurs in rat hepatocyte cultures following 
exposure to various chemicals suggesting that such systems retain 
sufficient drug metabolising activity to activate chemicals such 
as paracetamol to their toxic intermediates (Green et al 1981; 
Acosta et al 1980). This is further supported by the use of 
hepatocyte cultures in co-culture employing other cell types as 
the target cells for cytotoxic metabolites generated by the drug 
metabolising enzymes of the hepatocytes (Acosta & Mitchell 1981; 
Fry & Bridges 19 77).
Many of the previously reported studies involving hepatocyte 
suspension or monolayer cultures employ only one or two 
biochemical end points which provides limited information on 
their relative contribution to cell death. Recent evidence 
indicates that chemical induced toxicity involves a number of 
molecular events and that it is probably inappropriate to employ 
a single biochemical parameter as a sensitive indicator of toxic 
injury. Monitoring a number of biochemical end points in order 
to assess perturbation of hepatocyte function may elucidate their 
relative contribution towards cell death and may also provide 
further insight into possible mechanisms of chemical induced 
toxicity. Hepatocyte cultures appear to be a suitable test 
system since they allow prolonged exposure to low concentrations 
of chemicals as well as a multiparametric evaluation using a 
single hepatocyte preparation.
Another main research area employing hepatocyte cultures, 
including adult human hepatocytes, is in the detection of 
metabolically activated chemical carcinogens. These studies 
mainly focus on specific end points of genotoxicity , the two most 
commonly used being unscheduled DNA synthesis (UDS) and 
hepatocyte mediated mutagenesis.
Measurement of UDS in rat hepatocyte cultures was first reported 
by Williams (1976) and this autoradiographic technique is.now 
extensively employed as a genotoxicity bioassay. UDS can also be 
induced in adult human hepatocyte cultures by a variety of
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Chemical carcinogens (Strom et al 1982, 1983a, 1983b; Martelli et
al 1986; Robbiano et al 1986; Butterworth et al 1984).
Hepatocyte mediated mutagenesis studies involve co-culture 
systems which utilise hepatocytes as a metabolic activation 
system and a mutagenic end point in another cell type. Such 
mutagenicity studies employ either human fibroblasts and rat 
hepatocytes (Michalopoulos et al 1981) or, more recently, a 
combination of human fibroblasts and human hepatocytes to detect 
mutations induced by diethylnitrosamine (Strom et al 1983b).
Adult human hepatocyte cultures are of particular advantage with 
regard to the relevance of data to the in vivo situation in man.
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Aims of the Project
1. Develop a method for obtaining large numbers of viable human 
hepatocytes from available liver samples (kidney donors).
2. Establish primary human hepatocyte cultures with a 
characterised structural and functional integrity especially 
with regard to cytochrome P450 monooxygenase activity.
3. Establish a simple storage system for liver tissue or 
isolated hepatocytes.
4. Investigate the response of a number of biochemical 
parameters, following exposure of hepatocyte cultures to 
various chemicals, to further elucidate their relative 
contributions to chemical mediated toxicity.
CHAPTER II
MATERIALS AND METHODS
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MATERIALS
Tissue
Animals: Male Wistar albino rats, University of Surrey strain,
200g-300g, food and water ad libitum.
Human liver tissue was obtained from kidney donors in accordance 
with current ethical and legal requirements. The age of donors 
varied between 1 and 60 years.
Apparatus
18 gauge X 32mm catheters were obtained from Abbocath 
Laboratories, Kent, England.
250 pm stainless steel grids were supplied by Endecotts, London, 
England.
Peristaltic pump (502S): Watson Marlow, Cornwall, England.
All tissue culture plastic was obtained from Becton Dickinson, 
Oxford, England.
Reagents
Ingredients for tissue culture medium, unless specified 
otherwise, were obtained from Gibco Ltd, Paisley, Scotland.
Enzymes - unless stated otherwise - insulin, hydrocortisone, 
Ficoll 400, collagen, osmium tetroxide and ethoxycoumarin were 
supplied by the Sigma Chemical Co., Dorset, England.
Trypan blue: Flow laboratories, Irvine, Scotland.
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Reagents for electron microscopy were obtained from Taab 
Laboratories, Berkshire, England.
Collagenase and dispase were obtained from Boehringer Mannheim, 
Sussex, England.
Giemsa, DMSO and Eosin were obtained from BDH Ltd, Dorset, 
England.
Heamotoxylin : Difco Ltd, Surrey, England.
ATP Monitoring Kit; LKB Instruments Ltd, Surrey, England
Test chemicals were supplied by FRAME, FRAME Head Office, 
Nottingham, England.
All other chemicals and solvents were of the highest grade 
available.
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METHODS
Isolation of Rat Hepatocytes
This biopsy perfusion technique was based on previously reported 
perfusion methods of Reese and Byard (1981), Strom et al (1982) 
and Rao et al (1976). The following procedure was adopted after 
a series of trial perfusions.
Reagents: 7 0% (^/y) ethanol
Calcium-free bicarbonate buffer comprising of:
142.00 mM NaCl 
4.37 mM KCl 
■ 1.24 mM KH2 PO4
24.00 mM NaHCO]
0.62 mM ' MgS0 ^.7H20 
0.62 mM MgCl26H 20
Calcium chloride, 250 mM (CaCl2 .2H2 0 )
Collagenase buffer: Identical in composition to
calcium free bicarbonate buffer but containing
5. OmM calcium chloride and collagenase (0 .5mg/ml
of buffer).
P.B.S. 'A':
1 litre of distilled water containing:
8.00g NaCl 
0.20g KCl 
1 .15g NazHPO^
0 .20g KH2PO4
Bolting cloth, 125 pm pore size (Nybolt)
Fig 2 Recirculation Apparatus for Perfusion of Rat and 
Human Liver Biopsies
18 gauge needle
liver biopsy
xrzzxTiTzzpriJ
250^m stainless 
steel grid
37m m  air filter
carbogenr-
water bath ( 40*C)
perfusate
peristaltic pump
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Procedure :
The procedure was performed aseptically and solutions were filter 
sterilised (0.2 pm pore size), except for collagenase buffer 
(0.45 pm pore size). The perfusion tubing was flushed with 70% 
ethanol followed by sterile double distilled water. The buffered 
solutions were maintained at 40°C and continuously gassed with 5% 
002:95% O2 during perfusion.
Animals were killed by cervical dislocation, the abdomen swabbed 
with 70% ethanol and the abdominal cavity opened up to enable the 
whole liver to be removed without puncturing the hepatic capsule. 
The freshly excised tissue was washed in PBS ’A ’ and dissected 
into the individual lobes. Lobes most frequently selected for 
perfusion were; the larger lobe of the bilobular median lobe, 
wedge-shaped lobe of the right lateral lobe and the left lateral 
lobe. Each lobe was cut so as to maximise the volume of tissue 
available for perfusion and was entirely surrounded by an intact 
hepatic capsule with the exception of one cut surface.
Samples were transferred onto the stainless steel grid (Fig 2) 
and an 18 gauge needle of a plastic polythene catheter was 
inserted into the largest blood vessel exposed on the cut surface 
(1-3 rat liver samples were perfused simultaneously). Blood was 
flushed from the sample - usually within 2 minutes - with 
calcium-free bicarbonate buffer at a perfusion rate of 
1Oml/min/catheter; the position of the needle being adjusted to 
achieve maximum blanching. The flow rate was then increased to 
25ml/min/catheter and the perfusate allowed to drain. After 10 
minutes the perfusate was changed to the collagenase buffer which 
was recirculated at 20ml/min/catheter for 15 minutes or until the 
tissue appeared suitably digested. The liver tissue was placed 
into PBS *A’ and gently teased apart; the resulting cell 
suspension filtered through bolting cloth and centrifuged for 2 
minutes at 50 x g . The hepatocyte pellet was subsequently washed 
twice in PBS ’A*, resuspended in L 15 medium and cell viability 
assessed.
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Isolation of Human Hepatocytes
The method was similar to that of the biopsy perfusion technique 
described for rat liver with a few modifications necessitated by 
the more fibrous nature of human liver. The enzyme buffer was 
similar to that used by Mitchell (1985) for isolating hepatocytes 
from slices of human liver.
Reagents: As described for rat hepatocytes with the
following exceptions:
PBS 'A* + 0.5mM EGTA (sterile)
Enzyme buffer (sterile)
100 ml calcium free buffer containing:
150 mg Dispase
50 mg Collagenase
50 mg Hyaluronidase
5 mg Deoxyribonuclease I
5.0 mM Calcium chloride
Procedure :
Liver biopsies taken from the edge of a lobe were trimmed to 
leave a wedge shape sample entirely surrounded by an intact 
hepatic capsule with the exception of one cut surface. The 
thickness between the edge of the capsule and the cut surface did 
not normally exceed 4 cm and the length of the cut surface was 
about 6 cm. (Weight range of samples was 7-30g.)
Three 18 gauge needles were inserted into the largest vascular 
orifices that could be identified on the cut surface. Blood was 
flushed from the sample with 0.5 mM EGTA in PBS ’A', at a rate of 
25 ml/min/catheter. After 4 minutes the sample was perfused with 
calcium-free bicarbonate buffer at the same rate for 10-15 
minutes, solutions were then allowed to drain. The enzyme buffer
-  30  -
was recirculated (Fig 2) at 25 ml/min/catheter until the tissue 
appeared suitably digested; this took approximately 30 minutes.
At the end of the perfusion process the liver sample was 
suspended in PBS ’A ’, minced with scissors, and the resulting 
material filtered through bolting cloth. The remaining fragments 
were resuspended in PBS ’A ’, minced again, refiltered and pooled 
with the initial filtrate. The cell suspension was washed and 
hepatocytes counted as described for rat hepatocytes.
Determination of Hepatocyte Viability
Viable cells exclude certain polar dyes - such as trypan blue - 
whereas non viable, membrane damaged cells do not. This method 
was used to assess the yield of viable cells obtained from 
hepatocyte preparations and to determine changes in cell 
viability following cryopreservation of isolated hepatocytes.
Reagents: Trypan Blue dye, 0.5% (^/y) solution in 0.85%
(^/y) saline.
Procedure:
Trypan Blue dye (lOOpl) was added to an equal volume of the 
hepatocyte suspension and gently mixed. The number of non­
stained cells and the total number of cells were counted using a 
haemocytometer ; this permitted rapid assessment of isolation 
procedure quality.
Preparation of Primary Monolayer Cultures of Rat and 
Human Hepatocytes
The method used was similar to that currently employed within the 
Robens Institute for monolayer culture of rat hepatocytes.
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Reagents : Complete L15 medium
Liebowitz L15 medium containing:
Foetal calf serum (heat inactivated)
Tryptose phosphate broth
Insulin
Hydrocortisone hemisuccinate
Penicillin G
Streptomycin
10% (V/y)
10% (V/y)
10-G M 
10"5 M 
100 U/ml 
100 jag/ml
Procedure :
Freshly isolated hepatocytes (rat and human) were seeded at 2 x 
10^ viable cells in 4 ml complete L15 medium for 25 cm^ tissue 
culture flanks and at 0.3 x 10^ viable cells in 0.6 ml complete 
L15 medium for 24 well tissue culture plates. After 3-4 hours 
the medium containing non-attached cells was replaced with fresh 
medium. Subsequent medium changes were made every 24 hours.
Cryopreserved hepatocytes were treated similarly except that 
hepatocytes were seeded on collagen coated plastic in complete 
L 15 medium at 4°C and subsequently warmed to 37°C in an 
incubator.
Cell attachment was calculated from the number of non-attached 
cells at the first medium change as results were less variable 
than cell counts following trypsinisation of attached cells. 
Cellular protein content of hepatocyte cultures was also used to 
assess hepatocyte attachment.
Storage of Rat Liver Prior to Enzymic Perfusion
Reagents : PBS 'A '
Calcium free bicarbonate buffer.
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L15 medium containing penicillin, streptomycin 
(100 U/ml, 100 pg/ml) and 10% (^/y) foetal calf 
serum.
L15 medium containing penicillin streptomycin 
(100 U/ml, 100 pg/ml)
Procedure :
Samples of rat liver, removed at time of death, were immediately 
placed in the various solutions and maintained at 4°C until 
hepatocyte isolation. Perfusion of zero time samples commenced 
within V 2 hour of liver excision. Samples for freezing were 
placed in L15 antibiotic medium and frozen, either in a -80°C 
freezer or in the vapour phase of a liquid nitrogen Dewar.
Cryopreservation of Hepatocytes
This method of cryopreservation was optimised for rat hepatocytes 
and then applied to human hepatocytes.
Reagents : PBS ’A ’
LI5 Freezing medium : L15 medium containing 
penicillin, streptomycin (100 U/ml, 100 pg/ml),
10% (^/y) FCS, 10% (V/y) TPB and 20% (^/y) DMSO.
LI5 freezing medium + 50% (^/y) Ficoll 400
LI5 medium containing 1 M glucose.
Freezing Procedure:
Freshly isolated hepatocytes were resuspended in PBS 'A* (room 
temperature) and then cooled on ice to 4°C.
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Cell viability was determined and hepatocytes resuspended in pre 
cooled (4°C) L15-Ficoll medium at 10 x 10^ viable cells per ml. 
The cell suspension was dispensed into freezing ampoules, total 
volume 1 ml per ampoule. Cells were frozen in the vapour phase 
of a liquid nitrogen Dewar using a ’Handifreeze’ freezing tray 
(Union Carbide) set at the maximum freezing rate position. Cells 
were cooled to a temperature of below 150°C (approximately 20-30 
mins) and then transferred into the liquid nitrogen Dewar.
In the dual cryoprotectant system high molecular weight compounds 
were dissolved in L15 freezing medium. In the case of FC-43 (an 
inert water immiscible liquid) hepatocytes were resuspended in 
freezing medium and then aspirated through the liquid (pre-cooled 
to 4°C) to obtain an emulsion which was then frozen.
Thawing Procedure:
Ampoules were rapidly warmed in a water bath (37°C). As soon as 
the cell suspension was partially thawed the cells were diluted 
in L15 medium containing 1 M glucose (4°C) to lower the DMSO 
concentration to less than 2% (^/^). The hepatocyte suspension 
was centrifuged (50 x g ), resuspended in complete L 15 culture 
medium (4°C) and cell viability determined.
Separation of Viable and Non Viable Hepatocytes by Percoll 
Density Gradient Centrifugation
The method used was similar to that described by Dalet et al 
( 1982).
Reagents: 36% ( /^ ) Percoll in PBS *A’
Procedure :
Cryopreserved hepatocytes following thawing and dilution were 
resuspended in PBS 'A’ at a density of 6 x 10^ cells/ml and
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diluted to 10^ cells/ml with a 36% Percoll solution. The cell 
suspension was centrifuged at 17,000 rpm (4°C) for 20 minutes in 
a Centrikon 2055 ultracentrifuge. The supernatant was aspirated, 
the resultant pellet resuspended in excess PBS 'A ' and 
centrifuged at 50 x g for 2 minutes. The final cell pellet was 
resuspended in culture medium and cell viability determined.
Preparation of Collagen Coated Plastic
The procedure was similar to that described by Dougherty et al 
(1 9 8 0 ).
Reagents: PBS 'A’ (sterile) + Glacial acetic acid, pH 4.2
PBS 'A '
Collagen Type VII, acid soluble from rat tail.
Procedure :
Rat tail collagen was dissolved at 0.5 mg/ml in PBS ’A ’/acetic 
acid. 0.2 ml was added to 25 cm^ tissue culture flasks 
containing 2 ml PBS ’A' and 50 pi added to 24 plate multiwells 
containing 500 pi PBS ’A'. The solution was allowed to stand at 
37°C overnight, the remaining solution aspirated and the collagen 
coated plastic washed twice in PBS ’A ’ before use.
Phase Contrast Photomicroscopy
Hepatocyte cultures were photographed with an Olympus PM-6 
camera, using an Olympus CK inverted microscope adjusted for 
phase contrast microscopy.
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Preparation of Hepatocyte Cultures for Electron Microscopy
The method was similar to that routinely used in The Robens 
Institute to prepare tissue samples for electron microscopy.
Reagents: Glutaraldehyde (EM grade)
0.1 M Cacodylate buffer
2% (^/y) Osmic acid (aqueous)
Ethanol (absolute) ,
Epon 812 resin
Procedure :
Cell cultures were fixed in glutaraldehyde (4%, ^/y) in 0.1 M 
cacodylate buffer for 2 hours; then washed in 0.1 M cacodylate 
buffer for at least 1 hour. Cultures were counterfixed in 1% 
buffered osmic acid in 0.1 M cacodylate buffer for 2 hours and 
then dehydrated in sequentially increasing concentrations of 
alcohol. Next, they were washed in an equal volumes mixture of 
Epon 812 resin and absolute alcohol, the mixture removed and the 
cultures left to allow residual alcohol to evaporate. Epon 812 
resin was then added and polymerised at 60°C for 48 hours. 
Sections (70-90 nm) were cut from the resin block using a LKB 
ultratome 111. Sections were stained with uranyl acetate and 
lead citrate and observed with a Joel 100B electron microscope.
Preparation of Liver Tissue for Histological Examination
The preparation and staining of tissue sections is a standard 
procedure within The Robens Institute.
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Reagents : Harris's haemotoxylin
Acid Alcohol - 1% hydrochloric acid -in 70% 
alcohol.
Scotts Tap Water 
1% Eosin (aqueous)
Procedure :
Sections were dewaxed in xylene, hydrated through graded alcohols 
and washed in tap water. Sections were stained in Harris's 
haeraotoxylin, washed in water, differentiated in acid alcohol, 
washed in Scott's Tap Water and finally counterstained in Eosin. 
The slides were then washed in tap water, dehydrated through 
graded alcohols, cleared in xylene and mounted.
Preparation of Microsomes from Hepatocyte Cultures
The method employed was similar to the procedure established 
within The Robens Institute for the preparation of microsomal 
fractions from rat liver.
Reagents : Tris-KCL buffer 20 mM Tris HCL containing 
1 . 15% KCL, pH 7.4
SET buffer 20 mM Tris-HCL containing 
0.25 M sucrose, 5.4 mM EDTA
Procedure
Hepatocytes were harvested from tissue culture flasks by scraping 
off the cells with a 'rubber policeman' into Tris-KCL buffer at 
4°C. Cells were homogenised using a sonic probe - Rapidis 
ultrasonic disintegrator 50 series - utilising 15 second bursts
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until the majority of cells had been disrupted, as observed 
microscopically. The cell homogenate was centrifuged at 8700 rpm 
(9000g) for 10 minutes in a MSE HS-18 centrifuge. The 
supernatant was centrifuged at 40,000 rpm (105000g) for 1 hour in 
a Centrikon 2055 ultracentrifuge and the resulting microsomal 
pellet resuspended in SET buffer. Samples were stored in liquid 
nitrogen until analysis, a period which rarely exceeded 2 weeks.
Determination of Cytochrome P450 Content
The method was that described by Omura and Sato (1964).
Procedure:
Sodium dithionite was added to microsomal suspensions and a
baseline recorded over 390-520 nm using a dual beam
spectrophotometer. Carbon monoxide was bubbled through the 
sample cuvette and the difference spectrum recorded over the 
baseline. Cytochrome P450 was calculated from the difference in
absorbance between the peak at 450 nm and the trough at 490 nm.;
Values were expressed as specific activity per mg of microsomal 
protein assuming an extinction coefficient of 91 mM”  ^ cm” .^
Effect of Test Chemicals on Hepatocyte Morphology
The effect of test chemicals on rat hepatocyte morphology in 
culture was examined at similar time points to those selected for 
studying the perturbation of hepatocyte biochemical integrity.
Reagents : PBS ’A '
Acid alcohol - 3 volumes ethanol .:
1 volume acetic acid
Giemsa, stain
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Sorensen's buffer - 0.04 M Na2HP0 ,^ 0.04M KH2 PO4
pH 7.2
Working Stain - 5% ( /y) Giemsa inV
Sorensen's buffer
Procedure:
Cultures were washed twice in PBS 'A' to remove any unhealthy 
loosely attached cells then flooded with acid alcohol and left 
for 15 minutes. The acid alcohol was replaced with 5% (^/ ) 
Giemsa; after 20 minutes cultures were rinsed with tap water, 
allowed to dry and observed microscopically.
Perturbation of Hepatocyte Biochemical Integrity by Test 
Chemicals
Procedure :
Test chemicals were dissolved in an appropriate solvent (as used 
for FRAME metabolism series of chemicals) and added to cultures; 
final volume of solvent did not exceed 1% (^/y) of the incubation 
medium. Vehicle control cultures received 1% (^/y) of the 
appropriate solvent. Three tenfold dilutions were selected for 
each chemical, the top dose selected was not overtly toxic as 
assessed by hepatocyte morphology in the initial dose finding 
study.
Rat hepatocytes were seeded in 24 well plates, triplicate wells 
being prepared for each parameter. Cultures were exposed to test 
chemicals at the first medium change and again at the subsequent 
24 hour medium change. Hepatocytes were maintained in culture 
for a further 72 hours and the medium not renewed. Biochemical 
parameters were assayed after 6 hours, 26 hours and 96 hours of 
culture.
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Human hepatocyte monolayer cultures were treated identically 
except a 2 hour exposure period was employed after 24 hours in 
culture.
Chemical Solvent Top Dose Selected
Paracetamol 
Cyclophosphamide 
Dini tropheno1 
Thioacetamide 
Ethylene Dibromide 
Bromobenzene
Methanol
Ethanol
DMSO
Ethanol
Ethanol
Ethanol
1 000. 0 jig/ml
1000.0 pg/ml 
100 0.0 pg/ml
1000.0 pg/ml 
0.5 >ig/ml
50.0 pg/ml
Cellular Protein Content of Hepatocyte Monolayer Cultures
The method used was the Bio-Rad protein assay (Bio-Rad 
Laboratories 1981).
Procedure;
Serial dilutions of bovine serum albumin were prepared to give a 
linear assay response from 200-1000 pg/ml, test sample 
concentrations were within this range. All samples and standards 
were solubilised in 0.5 M NaOH and treated in an identical 
manner.
Lactate Dehydrogenase Leakage in Hepatocyte Monolayer Cultures
Cytosolic enzymes, such as lactate dehydrogenase (LDH), are 
released into the extracellular medium following cytotoxic damage 
and are an indicator of cellular membrane integrity. The method 
used was similar to that described by Bergmeyer (1974).
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Reagents : PBS 'A '
Solubilizing agent: in 100 ml distilled water
0.9 g NaCl
0.1 g Triton X +100
0.1 g Bovine serum albumin
Procedure:
Hepatocyte cultures were washed with PBS ’A* and incubated for 
1-2 hours in fresh complete L15 medium. Medium was removed from 
the cells and an equal volume of solubilising agent was added to 
the cultures. LDH activity was measured in the extracellular 
medium, allowing for background activity, and then measured in 
the solubilized cell fraction. LDH activity in the extracellular 
medium was expressed as a percentage of the total activity.
Protein Synthesis in Hepatocyte Monolayer Cultures
Incorporation of ^^C leucine into acid precipitable material was 
measured using a method routinely employed within The,Robens 
Institute which was adapted from a number of sources.
Reagents : 14C Leucine (10 pCi/ml)
Procedure:
10% ( /y) Perchloric acid (PCA)
PBS 'A'
0.5 M NaOH
Hepatocyte cultures were washed in PBS 'A' and fresh culture 
medium containing 100 nCi/ml '^^ C leucine added. Following a 1
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hour incubation at 37°C the medium was removed, cultures were 
washed in PBS 'A' to remove non-incorporâted radiolabel and 10%
PC A added. Precipitated material was scraped from the plastic 
into the PCA solution and frozen at -20°C until analysis. 
Precipitates were washed in 10% PC A until negligible counts were 
obtained in the supernatant and then resuspended in 0.5 M NaOH. 
Aliquots were taken for liquid scintillation counting and protein 
determination. leucine incorporation was measured by
scintillation counting in Picofluor-30 using an LKB 1219 Rackbeta 
liquid scintillation counter. Results were corrected to 
disintegrations per minute (dpm) and expressed as specific 
activity (n mol ^^C leucine) per mg of cell protein.
Glutathione Content of Hepatocyte Monolayer Cultures
Thiols and other molecules possessing SH groups can be converted 
to their s-nitroso derivatives by a reaction which can be linked 
to the formation of a coloured azo dye. The method used was 
derived from that of Seville (1958).
Reagents : TCA Extractant 1 volume 20% (^/y) TCA (aq)
1 volume 4 mM disodium EDTA
2 volumes PBS ’A ’
Solution A: 1 volume of 0.01 M aqueous 
sodium nitrate : 9 volumes 0.3 
M HgSO^
Solution B; 0.5% aqueous ammonium 
sulphamate
Solution C: 1 volume of 1% aqueous 
mercuric chloride : 4 volumes 
of 3.4% sulphanilamide in 
0.4 M HCL
- 4 2  -
Solution D 0.1% solution of N-1 Napthyl' 
ethylenediamine 
dihydrochloride in 0.4 M HCL
Procedure;
TCA extractant was added to hepatocyte cultures. Precipitated 
material was scraped from the plastic, separated from the TCA 
supernatant by centrifugation and resuspended in 0.5 M NaOH for 
protein determination.
0.1 ml of the TCA supernatant was added to 0.5 ml solution A. 
After 5 minutes 0.2 ml solution B was added, samples were mixed 
and left for 2 minutes. 1 ml solution C was then added, 
immediately followed by the addition of 0.8 ml solution D. The 
solution was then mixed and after a 10 minute interval the 
absorbance read at 540 nm.
Standards gave a linear response over 0-25 jug/ml, test samples 
were within this range; glutathione content was expressed as n 
mol per mg of cell protein.
ATP and ADP Content of Hepatocyte Monolayer Cultures
The method used was the LKB-Wallac bioluminescent monitoring kit 
for ATP and ADP.
Reagents : PBS ‘A*
TCA Extractant 1 volume of 20% aqueous 
TCA (V/y)
1 volume of 4 mM aqueous 
disodium EDTA
2 volumes of PBS ’A ’
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Tris Acetate buffer 0.1 M Tris Acetate buffer 
containing 2 mM EDTA, pH 
7.75
ATP Monitoring Kit Firefly luciferase/ 
luciferin
ATP standard
Phosphoenol pyruvate
Pyruvate kinase
Procedure :
TCA extractant was added to hepatocyte cultures immediately 
following removal of culture medium. TCA precipitable material 
was scraped from the plastic, separated from the supernatant by 
centrifugation and resuspended in 0.5 M NaOH for protein 
determination.
An aliquot of TCA supernatant was diluted V ^ q in Tris acetate 
buffer and ATP and ADP content measured directly by a combined 
ATP/ADP bioluminescent assay using an LKB 1251 luminometer. 
Following measurement of ATP, ADP was converted to ATP by 
addition of pyruvate kinase and phosphoenol pyruvate. The linear 
range of detection for ATP was 10“ "^* - 10“  ^ M, test sample 
concentrations were within this range. Individual samples were 
calibrated by internal standardisation using an ATP standard. 
Correction was made for trace levels of ATP/ADP in the 
phosphoenol pyruvate. Results were expressed as nmol per mg of 
cell protein.
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Ethoxycoumarin-O-deethylase Activity of Hepatocyte Monolayer
Cultures
The method used was modified from that of Jacobsen et al (1974)
Reagents : 140 mM ethoxycoumarin in dimethylformamide
0.2 M glycine buffer, pH 10.4
p  glucuronidase, 5 mg/ml in 0.2 M acetate buffer, 
pH 4.5
Arylsulphatase (23 mg/ml) and D saccharic 
acid-1-4-lactone (11.4 mg/ml) in 0.2 M acetate 
buffer, pH 4.5
n-hexane
Diethyl ether (AR) containing 1.5% isoamylalcohol 
(AR)
Procedure:
Hepatocyte cultures were incubated in culture medium containing 
70 pM ethoxycoumarin for 1-5 hours, depending upon the age of 
cultures. Medium was removed, diluted in water and stored at 
-20°C together with appropriate blanks and standards until 
analysis. Cellular protein was solubilised in 0.5 M NaOH for 
subsequent determination.
Unmetabolised ethoxycoumarin was removed by extraction of samples 
in hexane and free hydroxycoumarin was separated from more polar 
conjugation products by extraction in diethyl ether. The 
conjugation products were enzymatically cleaved to release free 
hydroxycoumarin following overnight incubation in the appropriate 
enzyme solutions and the resulting free metabolite extracted in 
diethyl ether. Free hydroxycoumarin was back extracted into
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glycine buffer and fluorescence measured using a Perkin Elmer 
Luminescence Spectrometer at an excitation of 370 nm and emission 
at 450 nm. Results were expressed as nmol per mg of cell protein 
per hour.
Statistical Evaluation
Mean and standard error of the mean (SEM) are stated where 
applicable. Statistical difference was determined by the paired 
students 't' test.
CHAPTER III
STRUCTURAL AND FUNCTIONAL INTEGRITY OF 
RAT HEPATOCYTE MONOLAYER CULTURES
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Isolation of Rat Hepatocytes
The average yield of hepatocytes obtained from biopsy perfusion 
was 24i 8.9 x 10^ viable cells/g liver wet weight (n=30). 
Hepatocyte preparations routinely had a viability between 85% and 
95%; initial cell attachment was between 74% and 86%.
An initial series of trial perfusions (data not shown) indicated 
that hepatocyte yield - but not cell viability - was improved by 
employing a water bath temperature of 40°C rather than 37°C. A 
slightly improved yield was also obtained by perfusion of samples 
at a rate of 25-30 ml/min/catheter instead of a slower rate. 
Perfusion employing a Hepes based buffer did not significantly 
alter either hepatocyte yield or viability.
Appearance of Rat Hepatocyte Monolayer Cultures
a) Phase Contrast Microscopy
Rat hepatocytes had attached and started to flatten within 4 
hours of plating (Fig 3a). Each cell had a round nucleus with a 
prominent nucleolus and many hepatocytes were binucleate. After 
24 hours hepatocytes had spread out to form a near confluent 
monolayer and exhibited a typical epithelial morphology (Fig 3b) 
Cells were maintained in culture for 8-10 days with only slight 
changes in cell shape. However, after 4-5 days cell boundaries 
were less distinct. Fig 4 illustrates the typical appearance of 
rat hepatocytes after 48 and 96 hours in culture.
b) Electron Microscopy
After 24 hours, rat hepatocytes exhibited many ultrastructural 
features characteristic of normal liver parenchymal cells in 
vivo; the cytoplasm containing abundant organelles. Numerous 
mitochondria with well defined cristae were present and membrane 
structure - including the endoplasmic reticulum - was well 
preserved (Fig 5). Cell-cell contact was evident indicated by
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the presence of tight junctions, desmosome-like junctions were 
observed on the plasma membrane of adjacent cells (Fig 5). No 
observable changes were apparent after 48 hours in culture as 
shown in Fig 6 which illustrates the presence of structures 
similar to bile canniculae. Microvilli projecting into the 
intercellular space were evident and nuclear structure was well 
preserved (Figs 5 and 6). Golgi apparatus was not easily 
identifiable and autophagic vacuoles which appeared to contain 
cell debris were observed in 48 hour and 96 hour cultures (Figs 6 
and 7). There was a progressive decrease in the number of 
organelles as well as a loss of membrane definition, in 
particular, the mitochondrial cristae and endoplasmic reticulum 
membranes (Fig 7). An increase in cytoskeletal elements 
involving an accumulation of microfilaments beneath the plasma 
membrane was noted (Fig 7).
Cytochrome P450 Content of Rat Hepatocyte Monolayer Cultures
Cytochrome P450 content of freshly isolated adult rat hepatocytes 
was O.4I 0 .O8 nmoles/mg of microsomal protein (n=5). Fig 8 
illustrates the cytochrome P450 content of rat hepatocyte 
monolayer cultures. Within the first 24 hours following plating 
cytochrome P450 content declined by 60%, but levels remained 
fairly constant over the next 48 hour period before falling to 
around 10% of the initial value.
Cytochrome P450 monooxygenase activity in rat hepatocyte cultures 
was measured using 7 ethoxycoumarin, a substrate for most of the 
isoenzymic forms of cytochrome P450. Ethoxycoumarin-O-deethylase 
(ECOD) activity in rat hepatocyte cultures is shown in Fig 9. 
After 4 hours in culture ECOD activity was 10.4 nmoles/mg 
protein/hour, this activity only falling 20% after 96 hours. 
Conjugation activity with both sulphate and glucuronide appeared 
to be maintained, the sulphate : glucuronide ratio remaining 
unchanged up to 96 hours.
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Biochemical Integrity of Rat Hepatocyte Monolayer Cultures
Fig 10a illustrates the increase in leakage of LDH into the 
extracellular medium with time in culture.
Protein synthesis, as measured by the incorporation of 
leucine into acid precipitable material, exhibited a slight 
increase with age of culture (Fig 10b).
ATP content of rat hepatocyte cultures steadily decreased with 
time (Fig 11a) whereas cellular ADP content remained fairly 
constant. Consequently, the cellular energy status, as indicated 
by the ATP/ADP ratio, also decreased.
Hepatocyte,glutathione content tended to increase over the first 
24 hours, levels decreasing slightly over the next 72 hours (Fig 
11b).
Discussion
The biopsy perfusion technique offers several advantages over 
the in situ whole liver perfusion method originally developed by 
Berry and Friend (1969) and the non perfusion liver slice 
technique of Fry et al (1976). These advantages include:
1. Easily performed under sterile conditions
2. Surgical expertise not required
3. Home office licence not required
4. Applicable to different size rats and to many other species
5. Large number of hepatocytes (50-70 x 10^ viable cells per
sample) isolated simultaneously from between 1-6 different 
rat liver samples
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The yield of hepatocytes per gram of tissue compared favourably 
with that of the in situ perfusion method currently employed 
within the Robens Institute. It was greater than that obtained 
using the liver slice method described by Fry et al (1976), 13 x
10^ viable cells/g liver, and similar to yields previously 
reported in other laboratories for either in situ or biopsy 
perfusion (Seglen 1976a; Guguen-Guillouzo & Guillouzo 1986; Green 
et al 1983).
Perfusate flow rates in the region of 25 ml per minute for 3-5 g 
samples were optimal; this probably reflected a more uniform 
penetration of the collagenase buffer into the tissue and maximal 
oxygenation of the sample. These factors have been reported to 
be extremely important for successful liver perfusion (Seglen 
1976a). The slightly improved yield using a water bath 
temperature of 40°C may have been the result of a more efficient 
enzymatic breakdown of tissue. Strom et al (1982), employing 
perfusion tubing of similar dimensions, reported optimal yields 
and a perfusate delivery temperature of 37°C with a water bath 
temperature of 42°C.
Appearance of rat hepatocyte cultures at light and electron 
microscope levels was similar to that previously described by 
Bissell et al (1974), Miyazaki et al (1985), Guguen et al (1975), 
Isom et al (1985) and Reid and Jefferson (1984). Typical 
parenchymal cell morphology was maintained for several days in 
culture. After 4 hours in culture hepatocyte ultrastructure was 
comparable to that of freshly isolated hepatocytes and 
parenchymal cells in vivo (Berry and Friend 1969; Moldeus et al 
1974).
Cytochrome P450 content of microsomal fractions prepared from 
freshly isolated rat hepatocytes was within the range of values 
exhibited by microsomal fractions obtained from intact rat liver 
using a procedure employed routinely within the Robens Institute 
(P450 content of non induced rat liver microsomes 0.3-0.7 n 
mol/mg microsomal protein). The cytochrome P450 content of
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freshly isolated hepatocytes reported here was also similar to 
that obtained in other laboratories (Lafranconi et al 1986; Green 
et al 1983; Grant et al 1985; Lake & Paine 1982; Englemann et al 
1985)
The decrease in cytochrome P450 content within the first 24 hour 
of culture was of similar magnitude to that reported by Fry et al 
1980; levels remaining steady over the subsequent 72 hours in 
culture. Other literature indicates a 40%-80% initial decrease 
in cytochrome P450 levels, followed by a further steady decrease 
of varying magnitude with time in culture (Guzelian et al 1977; 
Englemann et al 1985; Guillouzo 1986). Inter-strain differences 
and culture medium conditions might explain the observed 
variations in cytochrome P450 content of hepatocyte cultures. 
Recently, Grant et al (1986) demonstrated that various culture 
media differed markedly in their ability to maintain cytochrome 
P450 levels in culture. A strain difference has also been 
observed with certain monooxygenase activities (Green et al
1983).
Cytochrome P450 activity, as measured by ECOD activity, appeared 
to be maintained at a fairly high level in contrast to the 
spectrophotometrically determined cytochrome P450 content which 
exhibited a marked decline after 96 hours. This variation might 
reflect the greater sensitivity of the ECOD assay and the 
specificity of the methods involved. ECOD is a highly sensitive 
assay of monooxygenase enzymes and a substrate for a number of 
cytochrome P450 isoenzymes which exhibit varying activity towards 
ethoxycoumarin (Edwards et al 1984). ECOD activity was similar 
to that reported by Gwynn (1981) for 24 hour cultures. The 
observed decrease of activity with time was slightly less than 
that reported by Edwards et al (1984) and Warren et al (1985), 
possibly a reflection of different culture conditions.
Conjugation activity with glucuronide and sulphate was apparent 
in 96 hour cultures, suggesting stability of the enzyme systems 
responsible and maintainance of adequate levels of ATP.
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Guillouzo (1986) reported that rabbit hepatocytes maintained the 
ability to form sulphate conjugates from the drug ketotifen for 
at least 7 days in culture. Grant and Hawksworth (1986b), using 
1 napthol as a substrate, reported a decrease in 
sulphotransferase activity but an increase in glucuronosyl 
transferase activity of rat hepatocyte cultures after 72 hours in 
culture. Glucuronosyl transferase activity was maintained for up 
to 5 days in human hepatocyte cultures (Belleman et al 1979). 
Species and strain differences, isoenzyme specificity and culture 
conditions might account for the observed variations (Mulder
1984).
LDH leakage was of similar magnitude to that reported in the 
first 24 hour of culture by Mitchell et al (1985), Hayes et al 
(1986) and Hue et al (1985). Levels were generally lower than 
that of freshly isolated cells (Goethals et al 1984; Rikans & 
Hornbrook 1986; Van de Straat et al 1986), indicating that only 
the more healthy cells attach and spread out to form a monolayer.
Incorporation of radiolabel into acid precipitable material in 24 
hour cultures was comparable to that reported by Gwynn (1981),
but lower than that reported by Lafranconi et al (1986). Levels
after 4 hours in culture were similar to those reported for 
freshly isolated hepatocytes by Gwynn (1981) and Goethals et al
(1983), but lower than those of Hegarty et al (1984) and Thor ét
al (1978). The tenfold variation exhibited might reflect 
differences in incubation conditions (Seglen 1976b) as well as 
inter-strain factors.
Cellular ATP levels in 4 hour cultures were similar to those 
reported for freshly isolated hepatocytes by Thor et al (1978), 
Hirata et al (1977) and Muller and Ohnesorge (1984) but higher 
than those of Gwynn (1981), Baur et al (1975) and Wiebkin et al 
(1979). Differences may reflect the physiological status of the 
animals prior to hepatocyte preparation, incubation conditions or 
the greater sensitivity of the bioluminescent assay in comparison 
to spectrophotometric methods. The latter is also suggested by
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the fact that ATP content in 2 4 hour cultures compared favourably 
to that reported by George et al (1982) using a similar 
luciferin/luciferase assay. The ATP/ADP ratios in 4 hour 
cultures were higher than that reported for isolated hepatocytes 
(Muller 1984; Sobell et al 1980), probably as a result of the 
removal of unhealthy cells on plating. Levels were of a similar 
order of magnitude to those reported in vivo using a freeze 
clamping technique (Cunningham et al 1986). The results suggest 
that the energy status of cultured hepatocytes more closely 
resembles that of hepatocytes in vivo.
Maintainance of cellular glutathione content in hepatocyte 
cultures was similar to that reported by Grant and Hawksworth 
(1986b), except that this author did not report an increase in 
glutathione content within the first 24 hours of culture.
However, the results of Gerson et al (1986) and Casini et al 
(1982) did indicate an increase in cellular glutathione over the 
first 8 hours of culture. Glutathione content in 4 hour cultures 
was within the range of values generally reported for isolated 
hepatocytes (Eklow-Lastbom et al 1986; Fariss et al 1985; Reed et 
al 1983; Thor et al 1979; Albano et al 1984; Sundheimer et al 
1982; Moldeus & Jernstrom 1983). A loss of hepatocyte 
glutathione has been noted during isolation; this is followed by 
resynthesis which is dependant on incubation conditions, and 
often results in levels slightly higher than the theoretical 
glutathione level of hepatocytes in vivo (Hogberg & Kristoferson 
1977).
The structural and functional integrity of rat hepatocyte 
cultures prepared by biopsy perfusion was ostensibly similar to 
cultures prepared by in situ perfusion. This is in agreement 
with Green et al (1983) who observed no difference in the 
viability or metabolic function of isolated rat hepatocytes 
prepared by whole liver or biopsy perfusion.
Fig 3 Rat Hepatocyte Monolayer Cultures
After 4 hours (Magnification x 400)
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Fig 4 Rat Hepatocyte Monolayer Cultures
After 48 hours (Magnification x 400)
m
b) After 96 hours (Magnification x 400)
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Rat Hepatocyte Monolayer Cultures
Legend to Micrographs - Figs 5,6 and 7
m - mitochondrion
p - peroxisome
mv - microvilli
mf - microfilament
N - nucleus
Ns - nucleolus
gl - glycogen particles
dm - desmosome like structure
be - bile canniculae like structure
ER - endoplasmic' reticulum
Ld - lipid droplet
aV - autophagic vesicle
Fig 5 Rat Hepatocyte Monolayer Cultures After 
24 Hours (Magnification x 6000)
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Fig 6 Rat Hepatocyte Monolayer Cultures After 
48 Hours (Magnification x 6000)
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Fig 7 Rat Hepatocyte Monolayer Cultures After 
96 Hours (Magnification x 7500)
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Fig 8 Cytochrome P450 Content of Rat Hepatocyte
Monolayer Cultures
Results are mean ±SEM of 5 Separate hepatocyte 
preparations.
Cytochrome P450 content n moles P450/mg microsomal 
protein.
Results expressed as % of cytochrome content of 
freshly isolated hepatocytes.
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Fig 9 Ethoxycoumarin De Ethylase Activity of 
Rat Hepatocyte Monolayer Cultures
Results are mean ±SEM of 3 Separate hepatocyte 
preparations.
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Fig 10 Rat Hepatocyte Monolayer Cultures,
LDH Leakage and Protein Synthesis
Results are mean iSEM of 3 separate hepatocyte 
preparations.
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Fig 11 Rat Hepatocyte Monolayer Cultures, 
Cellular ATP, ADP and Glutathione
Results are mean ISEM of 3 separate hepatocyte 
preparations.
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CHAPTER IV
STORAGE OF RAT LIVER TISSUE 
PRIOR TO HEPATOCYTE ISOLATION
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Hepatocyte Yield and Viability Following Storage of Liver Tissue
L15 medium supplemented with 100 units penicillin/ml and TOO )ag 
streptomycin/ml at 4°C was found to be the optimal vehicle for 
storage of rat liver. A higher yield of viable cells was 
obtained than following storage in any of the other solutions 
investigated (Fig 12a & 12b).
Fig 13 illustrates the decrease in hepatocyte yield with storage 
time for rat liver samples stored at 4°C in L15 antibiotic 
medium. After 5 hours storage hepatocyte yields exhibited at 
least a 50% decrease, although cell viability was only slightly 
lower than that of cells isolated within ^ h o u r  of liver 
excision.
Rat Liver Histology; Influence of Storage Temperature
General liver cell architecture appeared normal following storage 
of samples overnight at 4°C (Fig 14a). However, at higher 
magnification many sinusoidal cell nuclei appeared pyknotic (Fig 
14b). Nuclei of cells at the periphery of the sample were mostly 
well preserved.
Storage of samples overnight at -80°C (Fig 15a) resulted in 
detachment of hepatocytes from one another but this did not 
appear to be associated with any particular region. Sinusoidal 
cell nuclei were generally well preserved although vacuolation of 
hepatocyte nuclei was evident throughout the sample (Fig 15b).
Hepatocytes throughout the sample were detached from one another 
following storage of liver tissue at -196°C (Fig 16a). In many 
regions, particularly near the edge of the sample, hepatocyte 
nuclei were either disrupted or vacuolated (Fig 16b).
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Rat Liver Ultrastructure; Influence of Storage Temperature
Fig 17 illustrates the typical ultrastructural appearance of rat 
liver tissue. Hepatocytes contain numerous organelles - 
mitochondria and rough endoplasmic reticulum are abundant - the 
plasma membrane and organelle membranes are well defined. 
Lysosomès are apparent in the region of the bile canniculae and 
some hepatocytes are binucleate. Glycogen deposits are evident 
and desmosomes are present along the plasma membranes of adjacent 
hepatocytes.
The ultrastructural appearance of hepatocytes in tissue stored 
overnight, irrespective of storage temperature, was markedly 
different from fresh tissue. Severe disruption of hepatocyte 
ultrastructural organisation was evident accompanied by a loss of 
glycogen deposits and rough and smooth endoplasmic reticulum. In 
tissue stored overnight at 4°C (Fig 18) extensive swelling of 
mitochondria and loss of membrane definition occured; autophagic 
vesicles and myelin bodies were also observed.
Storage of tissue at -80°C (Fig 19) resulted in extensive damage 
to cell organelles. Changes were more severe than those 
previously described and, in addition, the membranes of the golgi 
apparatus appeared dilated. Disruption of mitochondria, bile 
canniculae and endoplasmic reticulum was evident as indicated by 
the presence of non membrane associated ribosomes (Fig 19). 
Similar damage was apparent in tissue stored at -196°C.
Discussion
Storage of rat liver tissue prior to enzymic perfusion was 
investigated in response to the infrequent availability of human 
liver samples. Simple storage procedures were employed since 
more complex methods would have been impractical with regard to 
application to human liver tissue.
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Initial studies indicated that L15 medium was the preferential 
vehicle for storage and that perfusion should commence within 4 
hours of excision for optimal yield. Guguen-Guillouzo (1986) and 
Ballet et al (1984) have emphasised the importance of minimising 
the time between liver resection and perfusion in order to obtain 
high yields of human hepatocytes.
Liver epithelial cell outgrowths from samples stored for up to 5 
hours before initiation of cultures have been reported (Demoise 
et al 1971). Tisquaye (1978) isolated human foetal hepatocytes 
from samples stored at 4°C for up to 36 hours without any 
apparent deleterious effect on either morphology or albumin 
synthesis. However, attempts to culture rat hepatocytes from 
liver samples, irrespective of storage conditions described here, 
were relatively unsuccessful. This may reflect the severe 
cellular disruption that was observed microscopically in intact 
tissue following storage.
The presence of pyknotic sinusoidal cells in tissue following 
storage at 4°C was indicative of irreversible liver damage. 
Changes in liver cell architecture and vacuolation of hepatocyte 
nuclei at sub-zero temperatures suggested an excessive trauma to 
the cells. Changes indicative of gross hepatocellular injury 
following cryopreservation of liver tissue were also reported by 
Chamalaun et al (1973) using an isolated perfused rat liver 
system. A complete inhibition of bile production and urea 
synthesis, as well as high transaminase enzyme levels in the 
perfusate, were observed following cryopreservation. A 
detrimental response of similar severity was also reported for 
liver slices after cryopreservation (Fishbein & Stowell 1968).
Fig 12 Storage of Rat Liver Samples overnight 
at 4°C Prior to Biopsy Perfusion
Results are mean of 2 separate experiments
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Fig 14 Rat Liver Tissue Stored Overnight at 4°C
(haeraotoxylin and eosin)
Normal liver tissue architecture 
(Magnification x 40)
b) Pyknotic sinusoidal cell nuclei 
(magnification x 100)
Fig 15 Rat Liver Tissue Stored Overnight at -80°C
(haemotoxylin and eosin)
General liver tissue architecture showing
regions of hepatocyte detachment
(Magnification x 40
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b) Vacuolated hepatocyte nuclei 
(magnification x 100)
Fig 16 Rat Liver Tissue Stored Overnight at -196°C
(haemotoxylin and eosin)
a) General liver tissue architecture showing 
hepatocyte detachment 
(Magnification x 40)
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b) Disruption and vacuolation of hepatocyte 
nuclei (magnification x 100)
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Legend to Micrographs - Figs 17, 18 and 19 
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ER endoplasmic reticulum
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Fig 17 Rat Liver Tissue, Freshly Excised
(Magnification x 8000)
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Fig 19 Rat Liver Tissue Stored Overnight at -80 C
(Magnification x 16000)
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CHAPTER V
DEVELOPMENT OF A CRYOPRESERVATION METHOD 
FOR RAT HEPATOCYTES
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Hepatocyte Post Thaw Viability and Attachment;
Effect of Cooling Rate
Two methods of freezing were compared.
a) 'Hand ifreeze’ freezing tray (Union Carbide) set in the neck 
of a liquid nitrogen Dewar. Maximum cooling rate was
-15° C/min and minimum rate -1°C (based on manufacturers 
specifications).
b) Kryo 10 series controlled freezing chamber.
Initial results with the freezing tray indicated an optimal 
cooling rate in the region of -15°C/min compared to slower rates 
(Fig 20). Results exhibited a similar trend using the freezing 
chamber in that faster cooling rates, up to -30°C/min, appeared 
to improve subsequent hepatocyte survival in culture (Fig 21). 
Post-thaw attachment was a more sensitive indicator of hepatocyte 
survival in culture than post-thaw viability.
Effect of Low Molecular Weight•Cryoprotectants 
on Post-Thaw Viability
DMSG exerted a greater cryoprotective effect than glycerol 
(Fig 22). DMSO 20% (^/^) was optimal; hepatocyte survival was 
negligible in the absence of a cryoprotective agent.
Cell Density and Hepatocyte Survival
Two cell densities were compared, 10 x 10^ cells/ml and 4 x 10^ 
cells/ml, total freezing volume was constant at 1 ml. Cell 
survival was similar at either density (data not shown); the 
higher density was selected for subsequent use. Reducing the 
volume of freezing medium to a minimum, leaving a densely packed 
pellet of cells, resulted in a marked decrease in hepatocyte 
survival.
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Influence of Freezing Medium Composition 
on Post-Thaw Viability
Post-thaw variation in viability between separate experiments 
masked any subtle effect of freezing medium composition on 
hepatocyte survival. Both TPB and FCS appeared to exert a 
limited cryoprotective response (Fig 23) whereas insulin and 
hydrocortisone did not appear critical and were thus omitted from 
the optimal freezing medium. Increasing FCS concentration, up to 
20% (^Vy), appeared detrimental to cell survival as did 
replacement of FCS with BSA. However, hepatocyte post-thaw 
viability in a freezing medium consisting of FCS and 20% DMSO was 
similar to that of the optimal freezing medium. Addition of 1 M 
glucose did not improve hepatocyte survival.
Effect of Thawing and Dilution Procedure on Hepatocyte Survival
Post-thaw viability and attachment were variable between 
experiments but rapid thawing appeared optimal and immediate 
dilution of DMSO concentration to less than 2% (^/y) aided 
hepatocyte attachment (Fig 24). Subsequent hepatocyte cultures 
seemed healthier after dilution at 4°C in L 15 medium containing 1 
M glucose but there was no significant improvement in cell 
attachment.
Use of a Dual Cryoprotectant System
The presence of high molecular weight compounds - such as 
Metrizamide, Nycodenz, FC-43 (Maxidens) or Poly Ox 300 - in a 
dual cryoprotectant system with 20% (^Vy) DMSO did not improve 
hepatocyte survival (Figs 25 and 26). A cell suspension in L 15 
freezing medium aspirated through precooled FC-43 (-20°C) to 
freeze cells resulted in a low post-thaw viability. L15 freezing
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medium containing either 1% (^/y) polyvinyl pyrrolidone or 30%- 
50% (^/y) Ficoll 400 in a dual cryoprotectant system exhibited a 
slight; but not significant, improvement in hepatocyte post-thaw 
viability and attachment (Fig 27).
Discussion
Cell survival following cryopreservat ion is dependant on a 
complex inter-relationship between many variables (Farrant 1970). 
Consequently, similar survival rates might be achieved by 
different cryopreservation regimes and direct comparison of 
inter-laboratory results may be extremely misleading if they 
involve more than one variable. A further complication concerns 
measurment of cooling rates, a subject fraught with many 
practical difficulties (Farrant & Ashwood-Smith 1980) since 
cooling rates quoted as linear often exhibit non-linearity.
A similar trend was observed using either method of freezing in 
that faster cooling rates were optimal. Initial results obtained 
with the Kryo 10 chamber further suggested an optimal rate above 
which survival was reduced. An intermediate cooling rate, 
dependent on various cryoprotective variables, which allows some 
survival is reported to be a phenomenom generally applicable to 
many biological systems (Farrant 1970). The results presented 
regarding the effect of cooling rates on cell survival were 
broadly similar to those of Gomez et al (1984), who observed an 
improved post-thaw attachment following cryopreservation at a 
cooling rate in the region of 39°C/min. In contrast. Le Cam et 
al (1976) reported that slower cooling rates in the order of 
2°C/min, compared to cooling rates between 10°C/min and 
100°C/min, resulted in improved hepatocyte survival as assessed 
by cell viability, insulin binding capacity and gluconeogenic 
activity. Cryopreservation of hepatocytes, with varying degrees 
of success, have been reported (Nutt et al 1980; Novicki et al 
1982; Jackson et al 1985; Fuller & James 1985; Maganto et al
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1986; Coundouris et al 1986). All employed various 
cryopreservation regimes; cooling rates being in the region of 
1°C/min.
DMSO appeared to be the cryoprotectant of choice for hepatocytes. 
Novicki et al (1982) and Jackson et al (1985) also reported an 
improved cryoprotective effect using DMSO compared to glycerol. 
Klebe and Mancuso (1983), who identified a number of 
cryoprotective agents for mammalian cells, found that DMSO was 
more effective than glycerol. DMSO was also reported to be less 
toxic than glycerol in isolated, perfused rat liver (Chamalaun et 
al 1970). An optimal concentration of 20% (^/y) DMSO for 
cryopreservation of rat hepatocytes was reported by Coundouris et 
al (1986), whilst Novicki et al (1982) observed that the decline 
in cytochrome P450 content in subsequent culture was reduced by 
supplementing the freezing medium with 20% (^/y) DMSO rather than 
10% (^/y). Sucrose (data not shown) did not exert a 
cryoprotective effect although it has been reported with other 
cell types (Farrant 1970).
In general, other hepatocyte cryopreservation protocols have 
involved cell densities between 3 and 10 x 10^ cells/ml with no 
apparent effect on cell survival. However, Fuller and James 
(1985) advocated against using a cell density in excess of 10 x 
10^ cells/ml since highly packed cell volumes are known to reduce 
survival of other cell types.
The apparent variation in cryoprotective effect of FCS was 
difficult to explain, the reduced survival at 20% (^/y) seeming 
anomalous. Coundouris et al (1986), using a slow cooling rate, 
found FCS concentration over the range 20-50% (^/y) not critical, 
but 60% (^/y) markedly reduced survival. In contrast, 
replacement of culture medium with FCS in a fast cooling regime 
was reported to improve hepatocyte survival (Gomez et al 1984).
An inter-relationship may exist between FCS and other 
cryoprotective variables, such as the rate of cooling. 1 M 
glucose did not exert a cryoprotective effect although various
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saccharides are known to act as cryoprotective agents for both 
living cells and organelles. Glucose, for example, is known to 
exert a oryoprotective effect for liposomes (Miyajima et al 
1986).
The thawing and dilution procedure employed by various research 
groups is very similar. In contrast, freezing protocols differ 
greatly. In general, results presented here are in agreement 
with other published data; rapid thawing at 37°C followed by 
dilution of DMSO concentration to below 2% (^/y) and subsequent 
resuspension in culture medium appears optimal. A slow thawing 
rate was found to be detrimental to cell survival. This confirms 
the general observation that slow thawing of mammalian cells 
frozen at relatively fast rates reduces survival (Farrant 1970). 
This increased cell injury is believed to occur from 
recrystallisation; a process of redistribution and growth of 
intracellular ice crystals which is an inverse function of 
thawing rate (Leibo et al 1970).
The beneficial effect of 1 M glucose in the dilution medium on 
subsequent hepatocyte cultures has also been observed by 
Rheinhardt and Pelli (1986). Fuller and James (1985) reported 
that the presence of 1 M glucose circumvents initial dilution 
shock. The precise mechanism is poorly understood but is 
believed to involve a membrane associated response. Glucose has 
been reported to stabilize liposome dispersion during freezing 
and thawing by a mechanism thought to involve formation of a 
’protective covering layer’ over the surface of the liposomes 
which prevents ice crystal formation within the aqueous phase of 
the phospholipid bilayer (Miyajima et al 1986).
Various high molecular weight non-membrane permeable compounds 
are reported to exert a cryoprotective effect (Farrant & Ashwood- 
Smith 1980). Klebe and Mancuso (1983) also noted synergism 
between various structurally unrelated high and low molecular 
weight cryoprotective agents. However, addition of increasing 
concentrations of either Metrizamide, Nycodenz and Poly Ox 300 to
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L15 freezing medium reduced hepatocyte survival. This was 
probably a result of increased osmotic stress since normal 
physiological osmolarity was exceeded. The compounds per se are 
relatively non-toxic to biological systems {Rickwood 1983).
A cryoprotective response is also reported for polyvinyl 
pyrrolidone using various mammalian cells (Knight et al 1977; 
Leibo et al 1970). A similar degree of cryoprotection to that 
exerted by DMSO was observed by Klebe and Mancuso (1983). 
Polymers, such as polyvinyl pyrrolidone, are believed to exert a 
cryoprotective effect by providing a ’protective coat’ for 
cellular membranes, similar to that proposed for various 
saccharides.
In contrast, addition of Ficoll 400 to L15 Freezing Medium did 
not appear critical to hepatocyte survival over a 1-50% (^/y) 
concentration range. At 50% (^/y) the improved appearance of 
subsequent cultures was indicative of an increased cryoprotective 
effect. Normal physiological osmolarity was not exceeded over 
this concentration range and cryoprotection was likely to be the 
result of altered physical properties of the cell suspension, 
including viscosity, subtle osmotic changes, and possible 
membrane associated effects (Farrant & Ashwood-Smith 1980).
L 15 medium containing 50% (^/y) Ficoll appeared optimal for 
hepatocyte survival following cryopreservation, although the 
total number of cells recovered was reduced as a result of the 
handling difficulties inherent with the more viscous solution. 
Rapid thawing of cells was optimal and subsequent monolayer 
cultures appeared healthier following initial dilution in L 15 
medium containing 1 M glucose.
Fig 20 Hepatocyte Post Thaw Viability and
Attachment Following Cryopreservation
a) Handifreeze Freezing Tray
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Results are mean iSEM of at least 3 separate 
experiments
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Fig 21 Hepatocyte Post Thaw Viability and
Attachment Following Cryopreservat ion
b) Kryo 10 Series Controlled Freezing Chamber
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Results are mean of at least 2 replicate samples
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Fig 22 Effect of Low Molecular Weight
Cryoprotectants on Hepatocyte Post Thaw
Viability
1 . L15 freezing medium + 20% '"/v ) DMSO
2. L15 freezing medium + 10% ('/v ) DMSO
3. L15 freezing medium + 10% ) glycerol
4. L15 freezing medium + 20% (V/v ) glycerol
5. L15 freezing medium only
L15 freezing medium : L15 medium containing 10% FCS,
10% TPB + antibiotics.
Results are mean iSEM of at least 3 separate experiments
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Fig 23 Effect of Frezing Medium Composition on
Hepatocyte Post Thaw Viability
1. L15 freezing medium 7*
2. Complete L15 medium
3. L 1 5 medium 8.
4. L15 medium + 10% FCS
5. PBS 'A' 9.
6. L15 freezing medium 10.
+ 15% FCS
L 15 freezing medium 
+ 20% FCS
L15 freezing medium 
(W/g FCS) + 4% BSA 
FCS
L15 freezing medium 
+ 1 M glucose
L15 freezing medium : L 15 medium containing 10% FCS, 
10% TPB + antibiotics. All solutions contain 20% 
DMSO.
Results are mean iSEM of 3 separate experiments
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Legend to Fig 24
Thawing and Dilution Procedure
1. Dilution V ^ q in cold L15 medium containing 1 M glucose
(4°C); cells resuspended in cold complete L15 medium (4°C 
and plated.
2. Dilution V ^ q in cold L 15 medium containing 1 M glucose
(4°C), cells resuspended in warm complete L15 culture mec 
(37°C) and plated.
3. Dilution  ^/ •] q in cold complete L15 culture medium (4°C) £ 
cells plated.
4. Dilution V-]q in warm complete L15 culture medium (37°C) 
cells plated.
5. As for 1 but cells resuspended in cold complete L15 medii
containing 1 M glucose (4°C) and plated.
6. As for 2 but cells resuspended in warm complete L15 medii
containing 1 M glucose (37°C) and plated.
7. As for 1 but cells thawed slowly at +1°C/min.
Results are mean iSEM of 3 separate experiments, with the 
exception of 6 (n=1). Cells used in 1-6 were from a single 
hepatocyte preparation, cells used in 7 were from a second 
hepatocyte preparation of equivalent quality.
Fig 24 Effect of Thawing Procedure on Hepatocyte
Post Thaw Viability and Attachment
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Fig 27 Effect of a Dual Cryopreservation System 
on Hepatocyte Post Thaw Attachment
Compounds dissolved in L15 freezing medium (L15 
medium containing 10% FCS, 10% TPB + antibiotics) 
Results expressed as percentage of post thaw 
attachment using L15 freezing medium.
Results are mean of 2 separate experiments.
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CHAPTER VI
CRYOPRESERVATION OF RAT HEPATOCYTES 
SUBSEQUENT MONOLAYER CULTURES
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Hepatocyte Post-Thaw Viability and Attachment
Hepatocyte post-thaw attachment was more variable for 
cryopreserved cells than for freshly isolated cells (Fig 28). 
Post-thaw viability indicated a decrease in hepatocyte survival. 
Attachment of oryopreserved hepatocytes, calculated from 
unattached cells in the medium 4 hours after plating, was 
approximately 70% that of freshly prepared cultures. However, 
cellular protein content, which exhibited less variation, 
indicated that the figure was closer to 60% (Fig 29). The total 
number of hepatocytes recovered following cryopreservation varied 
between 70% and 80%.
Percoll density gradient centrifugation of oryopreserved 
hepatocytes resulted in a cell suspension containing 95%-98% 
viable hepatocytes. Post-thaw attachment was improved and 
recovery of viable hepatocytes following density gradient 
centrifugation was about 85%.
Fig 30 illustrates that hepatocyte post-thaw viability and 
attachment do not appear to vary with cryogenic storage time over 
28 days.
Cellular Protein Content of Hepatocyte Monolayer Cultures
Cellular protein content appeared to be a good indicator of the 
number of healthy cells attached to the substratum as less 
healthy cells were easily detached by the washing procedure.
This method was used to compare the number of healthy hepatocytes 
remaining in monolayer culture from both freshly isolated and 
oryopreserved hepatocytes.
In freshly prepared cultures the number of hepatocytes remaining 
attached after 96 hours in culture was only 20% lower than that 
after 4 hours in culture, even if collagen coated plastic was 
employed.
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In contrast, following cryopreservation, the number of 
hepatocytes remaining in culture after 96 hours was 70% lower 
than that after 4 hours in culture; also initial attachment was 
only 55% that of freshly prepared cultures. Pre-coating of 
culture flasks with rat tail collagen slightly improved initial 
attachment but did not appear to halt the subsequent decline of 
the cultures (Fig 29). The rate of detachment in the first 24 
hours of culture was much higher for oryopreserved hepatocytes 
(25% decrease) than for freshly prepared cultures (10% decrease).
Primary Monolayer Cultures of Cryopreserved Hepatocytes
a) Phase Contrast Microscopy
Fig 31 (a and b) illustrates the appearance of cryopreserved 
hepatocytes within the first 24 hours of culture. Cryopreserved 
hepatocytes took longer to spread out following attachment, 
although after 24 hours (Fig 31b) the oells have spread out to 
form an incomplete monolayer. The amounts of cell debris and non 
viable cells present were much higher than for freshly prepared 
cultures (Fig 3a & 3b).
b) Electron Microscopy
The ultras truetural appearance of cryopreserved hepatocytes upon 
thawing and dilution was very similar to that of freshly isolated 
hepatocytes; organelle structure and definition were well 
preserved (Fig 32). Following a 4 hour period in culture (Fig 
33) cryopreserved hepatocytes contained abundant organelles, good 
membrane definition was maintained and their general appearance 
was similar to that of freshly prepared cultures.
However, after 24 hours (Fig 34), ultras truetura1 changes - 
similar to those occuring after 96 hours in freshly prepared 
culture - were evident. There was a general reduction in the 
number of organelles as well as a loss in membrane definition and 
structural organisation.
- 6 4 -
Cytochrome P450 Content of Cryopreserved Rat Hepatocytes
The cytochrome P450 content of cryopreserved rat hepatocytes 
immediately after thawing and dilution was approximately 70% that 
of freshly isolated hepatocytes. Levels after 24 hours in 
culture were similar to those of corresponding freshly prepared 
cultures (Fig 35). However, after 48 hours in culture, this 
value had fallen to below 50% of that of corresponding freshly 
prepared cultures. In a preliminary study the cytochrome P450 
content of cryopreserved rat hepatocytes, immediately following 
Percoll density gradient centrifugation, was similar to that of 
freshly isolated cells obtained from the same hepatooyte 
preparation.
Cytochrome P450 activity in 4 hour cultures appeared slightly 
lower in oryopreserved hepatocytes than in unfrozen cells, 
conjugation with glucuronide appearing unchanged. Conjugation 
with sulphate seemed to decrease by 25%, the amount of free 
metabolite being slightly elevated (Fig 36).
Following Percoll density gradient centrifugation, the cytochrome 
P450 activity of 4 hour monolayer cultures of cryopreserved 
hepatocytes was similar to that of freshly prepared cultures, 
conjugation activity with sulphate and glucuronide was also 
maintained at comparable levels (Fig36).
Cryopreserved Hepatocytes, Biochemical Characteristics
Table 2 illustrates the effect of cryopreservation on the 
subsequent biochemical integrity of rat hepatocyte cultures. In 
4 hour cultures LDH leakage was threefold higher; protein 
synthesis, cellular ATP and glutathione levels each exhibited a, 
40%-50% decrease. The ATP/ADP ratio was approximately threefold 
lower than in freshly prepared hepatocyte cultures.
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Hepatocyte cultures established from cryopreserved cells appeared 
healthier following Percoll density gradient centrifugation.
This was reflected by changes in LDH leakage, cellular ATP and 
GSH content and protein synthesis (Table 2).
Discussion
Hepatocyte survival, as assessed by post-thaw viability, compared 
favourably with that of Le Cam et al (1976), Maganto et al 
(1986), Fuller and James (1985) and Jackson et al (1985), 
irrespective of the different cryogenic conditions employed.
Post-thaw attachemt was similar to that reported by Jackson et al 
(1985) and Novicki et al (1982). Percoll density gradient 
centrifugation appeared to improve initial attachment but the 
level was still lower than that of freshly prepared cultures. 
Collagen coating also appeared to improve attachment and 
spreading of cryopreserved hepatocytes. The mechanism by which 
such substrata aid attachment is poorly understood but, onoe 
attaohed, hepatocytes may be more able to overcome the trauma of 
cryopreservation, Cellular protein content is a more sensitive 
assay of cell attachment than calculation of attachment 
efficiency. Hepatocyte post-thaw viability is not a sensitive 
indicator of subsequent survival in culture.
The length of cryogenic storage time, up to 1 month in liquid 
nitrogen, did not appear to alter hepatocyte survival. This is 
similar with observations for many mammalian oell types in 
cryogenic storage below temperatures of -130°C (Ashwood-Smith
1980). It is also in agreement with Kusano et al (1981) who 
reported that rat hepatocytes, frozen in liquid nitrogen, 
maintained specific functions at higher levels than those frozen 
at higher temperatures for periods up to 1 month.
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Hepatocyte morphology in monolayer culture was similar to that of 
freshly prepared cultures but the cells were slower to spread out 
following cryopreservation. This indicated an impairment of 
normal hepatocyte function; an observation also reported by 
Novicki et al (1982) and Gomez et al (1984).
Maintainance of hepatocyte ultrastructure following 
cryopreservation has been reported by Gomez et al (1984) and by 
Le Cam et al (1976). However, the latter authors did observe 
some evidence of mitochondrial injury involving a decrease in the 
number and definition of cristae. Changes in hepatocyte 
ultrastructure after 24 hours in culture were accompanied by 
detachment of some cells. This response may reflect either 
initial damage on freezing to processes critical for hepatocyte 
survival in culture or an increased sensitivity of the cells to 
subsequent culture conditions.
Cytochrome P450 content appeared to be maintained at similar 
levels to unfrozen cells. This was demonstrated by results 
following Percoll density centrifugation where cell viability of 
cryopreserved hepatocyte suspensions was comparable to that of; 
freshly isolated cell suspensions.
Maintainance of cytochrome P450 levels similar to that of 
unfrozen cells was reported by Coundouris et al (1986), Fuller et 
al (1980) and Novicki et al (1982). This is consistent with the 
finding that in subcellular fractions several microsomal enzymes 
are stable to cryopreservation (Deflora 1981).
The decline in cytochrome P450 content within the first 24 hours 
of culture was of similar magnitude to that noted by Novicki et 
al (1982). However, these authors observed only a 38% decrease 
in cytochrome P450 content during the first 24 hours of freshly 
prepared cultures.
ECOD activity in 4 hour cultures also suggested initial 
maintainance of monooxygenase activity and of glucuronide and
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sulphate conjugation capacity. ECOD and aminopyrine demethylase 
activities were reported to be maintained following 
cryopreservation by Coundouris et al (1986) and Jackson et al 
(1985). The latter authors, using a different cryopreservation 
regime, noted a greater decrease in activity in the first 24 hour 
of culture compared to unfrozen cells. Maintainance of 
monooxygenase activity was also indicated by Karlberg and 
Lindahl-Kiessling (1981), who reported that cryopreserved rat 
hepatocytes metabolised cyclophosphamide at similar rates to 
unfrozen cells.
In 4 hour cultures the various biochemical parameters assayed 
indicated that the quality of subsequent hepatocyte cultures was 
improved following Percoll density gradient centrifugation.
Fuller and James (1985), using a slow cooling regime, reported 
that protein synthesis was impaired following cryopreservation, 
while Nutt et al (1980) demonstrated that recovery was not 
apparent after 48 hours in culture if the freezing temperature 
was below -20°C. Protein synthesis appears to be a sensitive 
indicator of cellular injury following cryopreservation and seems 
to reflect the subsequent ability of hepatocytes to attach and 
spread out to form a monolayer culture (Gomez et al 1984).
Coundouris et al (1986 )observed a similar decrease in hepatocyte 
GSH content following cryopreservation. Various other hepatocyte 
functions including gluconeogenic activity, lipogenesis, urea 
synthesis and response to glucagon were also reported to be 
impaired in isolated hepatocytes following a slow cooling regime 
(Le Cam et al 1976; Maganto et al 1986) but not in hepatooyte 
cultures following a fast cooling regime (Gomez et al 1984).
Such results emphasise the importance of the time points at which 
various hepatocyte functions are assayed and of post-thaw 
handling procedures regarding possible recovery of cells from the 
stress imposed by cryopreservation.
Fig 28 Viability and Attachment of Freshly
Isolated and Cryopreserved Hepatocytes
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Results are mean iSEM of 6 separate experiments 
Attachment calculated from unattached cells in 
medium 4 hours after plating.
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Fig 29 Cellular Protein Content of Hepatocyte
Monolayer Cultures
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Results expressed as percentage of cell protein in 
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Fig 30 Effect of Cryogenic Storage Time on
Hepatocyte Post Thaw Viability and
Attachment
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Fig 31 Cryopreserved Rat Hepatocytes in Primary
Monolayer Culture
After 4 hours (Magnification x 200)
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b) After 2 4 hours (Magnification x 200)
Rat Hepatocyte Monolayer Cultures Following Cryopreservation
Legend to Electron Micrographs - Figures 32, 33 and 34
M - mitochondrion
P - peroxisome
ER - endoplasmic reticulum
nucleus
LD - lipid droplet
Fig 32 Rat Hepatocytes Immediately After Thawing
and Dilution (Magnification x 7200)
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Fig 33 Cryopreserved Rat Hepatocytes in Primary
Monolayer Culture, After 4 hours
(Magnification x 3750)
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Fig 34 Cryopreserved Rat Hepatocytes in Primary
Monolayer Culture, After 24 hours
(Magnification x 3750)
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Fig 35 Cytochrome P450 Content of Rat Hepatocytes
Following Cryopreservation
Results are expressed as percentage of P450 content 
of freshly isolated hepatocytes. Results are mean 
of 2 separate experiments.
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Fig 36 Ethoxycoumarin De Ethylase Activity of
Rat Hepatocyte Monolayer Cultures
Following Cryopreservation
Results are mean iSEM of 3 separate experiments, 
except density gradient centrifugation data (DGC) 
Activity measured after 4 hours in culture.
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CHAPTER VII
HUMAN HEPATOCYTE MONOLAYER CULTURES
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Isolation of Human Hépatocytes
Collagenase alone appeared insufficient to suitably digest human 
liver, addition of dispase, deoxyribonuclease and hyaluronidase 
tending to produce a more uniform dispersion. Blanching of liver 
tissue was obtained by employing a higher perfusion rate than 
that used for rat liver. Rapid clearance of blood from the 
sample, as indicated by initial blanching, was difficult to 
achieve if the delay between liver resection and perfusion was in 
the region of 2-3 hours.
The yield of human hepatocytes was 4-8 x 10^ viable cells per 
gram liver wet weight (n=3). Hepatocyte viability was 92%-98%. 
Further incubation of minced material in fresh enzyme solution at 
37°C for 30 minutes released less than 10% of the number of 
hepatocytes released on initial dispersion.
Human Hepatocyte Monolayer Cultures
In general, human hepatocytes were of smaller size than rat 
hepatocytes but adapted to monolayer culture in a similar 
fashion. Human hepatocytes attach to tissue culture plastic 
within 4 hours of plating. Cells spread out within 24 hours (Fig 
37a) and survive in monolayer culture for several days. Some of 
these cells are binucleate (Fig 37b). The amounts of cell debris 
and unattached cells were greater than for rat hepatocytes.
Biochemical Characteristics of Human Hepatocyte 
Monolayer Cultures
Various biochemical parameters were assayed after 24 hours in 
culture (Table 3). LDH leakage was of similar magnitude to that 
of 24 hour rat hepatocyte cultures, cellular glutathione content 
was also comparable. Incorporation of "*^ C leucine appeared to be
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lower in human hepatocyte cultures. Cellular ATP and ADP levels 
were higher in human hepatocyte cultures but the ATP/ADP ratio 
was lower compared to rat hepatocyte cultures.
Cryopreservation of Human Hepatocytes
Post-thaw viability of human hepatocytes indicated a slightly 
lower survival rate compared to rat hepatocytes frozen under 
similar conditions. The total number of cells recovered 
following cryopreservation was comparable to that of rat 
hepatocytes, 70%-85%.
Cryopreserved Human Hepatocytes in Monolayer Culture
The number of cryopreserved human hepatocytes attached within 4 
hours of plating was lower than that for rat hepatocytes (Fig 
38a). After 2 4 hours in culture (Fig 38b) human hepatocytes had 
spread out, some cells forming small island of 3-4 cells. 
Survival of cryopreserved human hepatocytes in culture was 
similar to that of rat hepatocytes.
Discussion
The yield of human hepatocytes was lower than those reported for 
other similar perfusion techniques, average reported yields are 
14-50 X 10^ viable cells per gram of liver (Strom et al 1982; 
Ballet et al 1984; Byard et al 1982; Lee et al 1985). In 
contrast to these other authors, despite perfusion conditions 
being very similar, collagenase alone appeared insufficient to 
suitably digest the tissue. A more uniform dispersion was 
obtained using a mixture of enzymes as described by Mitchell 
(1985) for isolation of human hepatocytes from liver slices.
— ' 7 0  —
The results strongly suggest that the low yields and the apparent 
inefficiency of collagenase reflect the time delay between liver 
resection and onset of perfusion. The majority of human liver 
samples received in this laboratory arrived at least 2 hours 
after resection; in the reports cited above, perfusion normally 
commenced within 1 hour of resection. Experience involving 
storage of rat liver tissue prior to enzymic perfusion indicates 
a reduction of more than 50% in hepatocyte yield after 3-5 hours. 
The importance of minimising the time delay between resection and 
onset of perfusion to less than 1 hour for human liver in order 
to obtain high yields has recently been emphasised (Guguen- 
Guillouzo 1986).
In monolayer culture human hepatocytes exhibit typical 
parenchymal cell morphology and retain ultrastructural 
characteristics not unlike those found in vivo (Maekubo et al 
1982; Strom et al 1982; Guillouzo et al 1972; Miyazaki et al
1981). LDH leakage indicated that the cellular viability of 
human hepatocytes was comparable to that of"rat hepatocytes. 
Various biochemical parameters indicative of cellular metabolic 
competence were also maintained at levels broadly similar to 
those of rat hepatocytes, suggesting that specific hepatocyte 
functions may be maintained to an extent not unlike that of rat 
hepatocyte cultures. The observed difference in rates of protein 
synthesis between rat and human hepatocyte cultures may reflect 
differences in isolation trauma or in vivo capacity; Gwynn (1981) 
suggested a species difference might exist for this parameter.
Post-thaw viability and attachment of human hepatocytes suggest 
that the cells may be more sensitive to freezing under the 
optimal conditions developed for rat hepatocytes. This may 
reflect either the altered physical properties of the cell 
suspension - due to the smaller size of human hepatocytes - or a 
greater sensitivity of the cells to cryopreservation. A 
reduction in survival of human hepatocytes following 
cryopreservation under an optimal regime developed for rat 
hepatocytes has also been reported b y •Coundouris et al (1986) and
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Guillouzo et al (1987). Optimisation of cryopreservation. 
conditions for human hepatocytes is severely hindered by the 
requirement for many preparations of equivalent viability and 
functional capacity, problems which do not apply to rat liver.
Morphological appearance of human hepatocyte cultures following 
cryopreservation was broadly similar to that of unfrozen cells. 
Cryopreserved human hepatocytes are reported to express specific 
functions in culture comparable to those of unfrozen cells 
(Guillouzo et al 1987). Moore and Gould ( 1984) observed that 
cryopreserved human hepatocytes retain the capacity to metabolise 
benzo(a) pyrene although cryopreserved cells produced more 7,8 
dihydrodiol than fresh cell cultures.
The ability to cryopreserve human hepatocytes from a single donor 
for multiple testing purposes is clearly desirable in order to 
maximise the potential use of infrequently available human liver 
samples. It also offers the potential for a storage bank of 
hepatocytes obtained from numerous individuals. Further 
characterisation of the functional capacity of cryopreserved 
hepatocytes and comparison of their ability to bioactiviate known 
xenobiotics with that of fresh hepatocyte cultures, may allow the 
use of such cells as a relevant pharmaco-toxicological model. 
Refinement of existing isolation and cryopreservation techniques 
may lead to a more widespread use and general acceptance of human 
hepatocyte model systems.
Fig 37 Human Hepatocytes in Monolayer Culture
After 2 4 hours (Magnification x 200)
» *
b) After 48 hours (Magnification x 200)
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CHAPTER VIII
CHEMICAL INDUCED CYTOTOXICITY IN PRIMARY 
MONOLAYER CULTURES OF RAT AND HUMAN HEPATOCYTES
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Introduction
The exposure regime for human hepatocyte cultures differed from 
that employed for rat hepatocytes. This was a result of 
practical difficulties involving the variable time of arrival of 
samples. Culture medium was renewed 3-4 hours after plating but, 
unlike rat hepatocyte cultures, human hepatocytes were not 
exposed to test chemicals until after 8-18 hours in culture 
depending upon the time of arrival of liver samples. However, 
exposure times were identical to those employed for rat 
hepatocyte cultures. Hepatocytes were often isolated from human 
liver samples between 2100 hrs and 0200 hrs.
Cytotoxicity of paracetamol and cyclophosphamide was investigated 
in human hepatocyte monolayer cultures prepared from a male 
hydrocephalic infant of 13 months. Cause of death was recorded 
as cardiovascular, the patient receiving cefuroxime, Magnapen and 
mannitol (unspecified doses). Dose levels were selected on 
previous experience of the cytotoxic response elicited by the 
test chemicals in a human derived cell line assay system in the 
presence of a metabolising fraction (S-9 mix), since 
corresponding data for rat hepatocytes was not available at the 
time.
Rat and Human Hepatocyte Monolayer Cultures;
Cytotoxicity of Paracetamol
a) Rat Hepatocyte Cultures
An increase in LDH leakage was apparent following a 24 hour 
exposure at 1000 pg/ml (6.6 m M ), a slight increase occuring at 
lower dose levels after 96 hours (Fig 39a).
Incorporation of radiolabel (Fig 39b) was impaired after a 2 hour 
exposure at 1000 ^g/ml, the degree of inhibition remaining at 
this level over the experimental period. Cellular ATP content
Fig 39 Exposure of Rat Hepatocyte Monolayer
Cultures to Paracetamol, LDH leakage and 
Protein Synthesis
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Fig 40 Exposure of Rat Hepatocyte Monolayer Cultures
to Paracetamol; ATP, ADP and ATP/ADP Ratio
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Fig 41 Exposure of Rat Hepatocyte Monolayer 
Cultures to Paracetamol, Glutathione 
and ECOD Activity
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Fig 42 Exposure of Rat Hepatocyte Monolayer
Cultures to Paracetamol; ECOD Activity
□  sulphate conjugation products 
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Results are mean iSEM of 3 replicate samples.
3-4
10-r
3-2
9-- 2.8
6 - •
4 --
S 100 100010
3-2
6.3'V j:
S 10 100 1000
3.3
3-4
S 10 100 1000
9 6
Exposure Time (hours)
Dose levels - pg/ml, S - solvent control cultures.
Fig A3 Exposure of Human Hepatocyte Monolayer
Cultures to Paracetamol, LDH and Protein 
Synthesis
a) LDH leakage
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Cells exposed to paracetamol after 18 hours in culture 
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replicate samples.
Fig 44 Exposure of Human Hepatocyte Monolayer 
Cultures to Paracetamol; ATP, ADP and 
Glutathione
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(Fig 40a) appeared to decrease only at cytotoxic concentrations. 
However, the ATP/ADP ratio exhibited a time and dose dependant 
decrease (Fig 40c).
Hepatocyte GSH content (Fig 41a) also exhibited a time and dose 
dependant decrease. ECOD activity tended to decrease with 
increasing concentrations of paracetamol after 96 hours (Fig 41b) 
but neither sulphate nor glucuronide conjugation appeared to be 
inhibited to any significant degree (Fig 42).
b) Human Hepatocyte Cultures
LDH leakage tended to increase following a 2 hour exposure to 
paracetamol(Fig 43a), this was not observed in rat hepatocyte 
cultures. Protein synthesis (Fig 43b) exhibited a similar degree 
of inhibition to that observed in rat hepatocyte cultures.
Cellular ATP content (Fig 44a) decreased at a dose level which
tended to increase leakage of LDH as had been observed in rat
hepatocytes. However, the response in human hepatocytes appeared 
to occur at a lower concentration and after a shorter exposure 
time; 2 hours exposure at 100 ug/ml, compared to 24 hours
exposure at 1000 ug/ml in rat hepatocyte cultures. Hepatocyte
GSH content (Fig 44b) decreased in a manner not unlike that 
observed in rat hepatocytes, with the exception that a response 
was apparent at lower dose levels.
Discussion
Paracetamol is a commonly used analgesic and antipyretic drug. 
Although generally safe at therapeutic doses it produces 
hepatocellular necrosis when taken in overdose. Ingestion of 15g 
or above invariably leads to acute hepatocellular necrosis, the 
toxic dose for children is even lower (Davis 1982).
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Centrilobular hepatic necrosis following large doses of 
paracetamol occurs both in man and experimental animals (Timbrell 
1983; Hinson et al 1981). Toxicity is believed to be mediated by 
a reactive metabolite formed by the cytochrome P450 mixed 
function oxidase system, N-acetyl p-benzoquinoneimine has been 
proposed as a possible candidate. At normal therapeutic dose 
levels paracetamol mainly undergoes glucuronidation and 
sulphation with a small percentage being metabolised to the 
reactive metabolite. This appears to be effectively detoxified 
by conjugation with glutathione. However, at high concentrations 
conjugation with sulphate and glucuronide becomes saturated and 
extensive activation to the reactive metobolite occurs. This 
results in depletion of GSH levels and subsequent extensive 
covalent binding to thiol groups of cellular macromolecules.
The incidence and severity of hepatic necrosis appears to 
correlate with the extent of covalent, binding (Hinson et al 
1981). Paracetamol toxicity is potentiated in vivo and in vitro 
by agents that either deplete GSH content or induce cytochrome 
P450 .
Two processes, covalent binding of the reactive metabolite to 
cellular proteins and oxidative stress, are postulated as 
important steps in paracetamol hepatotoxicit y . These two 
mechanisms are both intimately associated with lowered cellular 
glutathione levels. Glutathione depletion by paracetamol is 
thought to arise by irreversible conjugation with the reactive 
metabolite and by reversible oxidation of glutathione (Fig 45).
A critical involvement of cellular thiols is further suggested by 
recent research involving dialkyl substitution of paracetamol and 
the observed difference in toxicity between the analogues. This 
appears to reflect the physicochemical properties of the parent 
analogues and their subsequent reactive intermediates, in 
particular, their interaction with sulphydryl groups on proteins 
and peptides (Van der Straat et al 1986; Porubek et al 1987).
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Fig 45 Postulated Pathways of Paracetamol Metabolism
H N -C -C H
H N -C -C H
SulphateGlucuronide
H N -C -C H .
2 GSH
+ 1e
OH
N —C —CH;
Cyt. P450
+1e" GSSG
N -C -C H .OH
+ H2O+ GSH
HN -C -C H ; Covalent Binding 
Lowered GSH
SG
OH
Cell Death
1 paracetamol, 2 acetamide, 3 N-acetylseraiimidoquinone, 
4 p-quinone, 5 N-acetylimidoquinone, 6 glutathione 
conjugate
(From Hinson et al 1981)
Rat hepatocytes seem relatively insensitive to paracetamol 
exposure. A similar delayed response involving leakage of LDH 
was observed in rat hepatocyte cultures by Mitchell et al (1985) 
and Hayes et al (1986) following exposure to high concentrations 
of paracetamol (5 x 10“  ^ M or above). Evidence of a time delay 
was also reported by Hue et al ( 1985) who found that following a 
4 hour exposure to paracetamol (5 x 10“  ^ M) no increase in LDH 
leakage was apparent until 24 hours later.
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In isolated rat hepatocytes a 4 hour exposure to paracetamol up 
to a concentration of 2.5 x 10“ M was reported to be non 
cytotoxic (Goethals et al 1984). These in vitro results appear 
comparable to the known in vivo situation since rats are 
generally regarded as a relatively insensitive species as far as 
paracetamol toxicity is concerned.
Inhibition of protein synthesis following paracetamol exposure 
has also been reported in isolated hepatocytes (Vonen & Moorland 
1984; Goethals et al 1984; Gwynn 1981). This marked decrease in 
incorporation of radiolabel is quite rapid, indicative of a 
direct effect on protein synthesis. The level of inhibition, 
however, did not appear to be directly influenced by cellular 
energy status. Goethals et al (1984) suggested that the decrease 
in incorporation of radiolabel resulted from a possible 
perturbation of amino acid transport systems of the hepatocyte 
membrane, whereas Gwynn (1981) postulated that impairment of 
activation of individual amino acids at the translation stage may 
be associated with an observed decrease in ATP levels. The 
latter hypothesis is not supported by the data obtained in this 
hepatocyte monolayer culture system.
Vonen and Moorland (1984) reported a similar decline in cellular 
ATP levels in isolated rat hepatocytes. The subsequent decrease 
in ATP/ADP ratios with exposure time suggested an impaired 
capacity to maintain cellular energy status, possibly involving a 
perturbation of inner mitochondrial function. Lowered 
glutathione levels appear to be associated with paracetamol 
cytotoxicity, a similar response is observed in other hepatocyte 
culture systems (Hayes et al- 1 986; Mitchell et al 1985) and in 
isolated hepatocytes (Moldeus & Jernstrom 1983).
Impairment of ECOD activity, following exposure to paracetamol, 
was indicative of a late toxic response which was, possibly, the 
result of a disturbance of other critical biochemical functions.
A more rapid inhibition of ECOD activity was observed in isolated
- 77 -
hepatocytes exposed to higher concentrations of paracetamol, 10- 
40 mM (Gwynn 1981). This author also noted a greater inhibition 
of conjugation with sulphate than glucuronide which appeared to 
be associated with low cellular ATP levels. However, no such 
response was evident in this hepatocyte culture system, a likely 
reflection of the difference in dose levels and exposure time.
Cytotoxicity of paracetamol in human hepatocyte cultures was 
broadly similar to that observed for rat hepatocytes. However, 
the results suggested that human hepatocytes may be slightly more 
sensitive to paracetamol exposure since a perturbation in 
hepatocyte metabolic competence was apparent at lower dose 
levels. The data may reflect the young age of the donor or other 
physiological factors which influence both xenobiotic metabolism 
and the subsequent toxic response (Dauterman 1980). In addition 
a fivefold interindividual variation in paracetamol oxidation 
rate is observed for human subjects (Boobis et al 1986) which 
will influence a toxic response. This highlights the requirement 
for extensive background information on human hepatocyte function 
to enable reliable interpretation of data generated in any human 
hepatocyte cytotoxicity assay.
Rat and Human Hepatocyte Monolayer Cultures;
Cytotoxicity of Cyclophosphamide
a) Rat Hepatocyte Cultures
An increase in LDH leakage (Fig 46a) was apparent following a 24 
hour exposure to 1000 pg/ml (3.8 mM). Incorporation of 
radiolabel (Fig 46b) tended to decrease at all 3 dose levels 
after a 2 hour exposure, however, this initial inhibition 
appeared transient. Cellular ATP content exhibited a time and 
dose dependant decrease at cytotoxic and non-cytotoxic 
concentrations (Fig 47a). The decline in ATP/ADP ratio (Fig 47c) 
broadly paralled ATP levels. Low hepatocyte GSH levels (Fig 48a) 
were associated with cytotoxicity (1000 pg/ml) and levels tended
Fig 46 Exposure of Rat Hepatocyte Monolayer
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and Protein Synthesis
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Fig 48 Exposure of Rat Hepatocyte Monolayer
Cultures to Cyclophosphamide, Glutathione 
and ECOD Activity
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Fig 49 Exposure of Rat Hepatocyte Monolayer
Cultures to Cyclophosphamide; ECOD Activity
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Fig 50 Exposure of Human Hepatocyte Monolayer
Cultures to Cyclophosphamide, LDH and Protein 
Synthesis
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Fig 51 Exposure of Human Hepatocyte Monolayer 
Cultures to Cyclophosphamide; ATP, ADP 
and Glutathione
a ) ATP and ADP content X —  ATP content 
• —  ADP content
X —100 —^  X
80
r—I
6 0 - -
20 - —
100
Cyclophosphamide (pg/ml)
b) GSH content
100 ~r
80
O
^  60
aoÜ
^ 40
20
TX
X  *
10 1Q9
Cyclophosphamide (pg/ml)
Cells exposed to cyclophosphamide after 18 hours in 
culture (2 hour exposure time). Results are mean ±SEM 
of 3 replicate samples. Significantly different from 
control levels, *p < 0.05.
- 78 -
to decrease following exposure to 100 pg/ml. ECOD activity (Fig 
48b) was also inhibited at cytotoxic concentrations and exhibited 
a decrease following a 96 hour exposure to 100 jjg/ml, Neither 
conjugation with sulphate nor with glucuronide appeared to be 
altered to a significant extent (Fig 49).
b)Human Hepatocyte Cultures
No significant increase in LDH leakage was apparent following a 2 
hour exposure (Fig 50a). Incorporation of radiolabel (Fig 50b) 
was notably inhibited at 100 pg/ml in a similar fashion to that 
observed for rat hepatocytes.
Cellular ATP and ADP levels remained unaltered (Fig 51a) as 
occured for rat hepatocytes at comparable concentrations. 
Hepatocyte GSH content (Fig 51b) exhibited a decrease at 100 
pg/ml which was not observed after a similar exposure time in rat 
hepatocytes.
Discussion
Cyclophosphamide is a widely used drug in the treatment of 
various neoplastic diseases and of certain diseases of 
immunological aetiology, including rheumatoid arthritis. It is 
also used as an immunosuppressive agent in patients undergoing 
organ transplantation.
Cyclophosphamide is inactive per se and requires metabolic 
activation to reactive metabolites capable of binding covalently 
to nucleic acids and proteins. The metabolic pathways are well 
documented (Fig 52) and cyclophosphamide is frequently used as a 
model cytotoxic chemical requiring metabolic activation (Fry 
1982).
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Fig 52 Postulated Metabolic Pathways of 
Cyclophosphamide
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pathways (Fig 52), Metabolism of cyclophosphamide in isolated 
rat hepatocytes is reported to resemble the,in vivo situation 
more closely than that of subcellular fractions (Bates et al 
1981). Factors which influence biotransformation, such as 
inducers like phénobarbital, may also considerably alter the 
potency of cyclophosphamide through changing the balance of 
competing metabolic pathways (Gurtoo et al 1985).
Phosphoramide mustard is thought to be responsible for both the 
antitumour activity and immunosuppression, the chloroethyl groups 
of the activated metabolite reacting preferentially with DNA. 
Acrolein is believed to be associated with the toxic side effects 
of cyclophosphamide administration, including haematuria and 
bladder toxicity as well as in vivo depression of hepatic 
monooxygenase activity. These toxic responses possibly result 
from the reaction of the double bond in acrolein with free 
sulphydryl groups in cellular proteins (Gurtoo et al 1981). The 
two known reactive metabolites of cyclophosphamide appear to be 
relatively stable as both cytotoxicity and genotoxicity are 
observed in mammalian cell lines co-cultured with rat hepatocytes 
as an activating system (Acosta & Mitchell 1981; Kligerman & 
Michalopoulos 1980) and with a rat liver S-9 fraction (Horner et 
al 1985).
Cytotoxicity was evident at the top dose o f ,cyclophosphamide 
studied, 1000 p g / m l  (3,8 mM) which was in contrast to a previous 
report describing minimal toxicity to neonatal rat hepatocyte 
cultures following a similar exposure. However, neonatal rats 
are generally thought to have lower cytochrome P450 levels than 
adults. Moreover, differences in animal strain and culture 
conditions may influence the response.
Inhibition of protein synthesis appeared reversible although 
activation of other compensating pathways may also explain the 
observed response. The decrease in ATP levels was not reversible 
and also occured at non-cytotoxic concentrations, a possible 
result of either an impaired synthesis or an enhanced breakdown.
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Low hepatocyte glutathione levels were associated with 
cytotoxicity which may point to covalent binding of a reactive 
metabolite to critical cellular macromolecules. Acrolein is 
reported to interact with sulphydryl groups at various sites of 
the cytochrome P450 apoprotein resulting in dénaturation and 
subsequent loss of activity (Gurtoo et al 1981). Glutathione 
appears to exhibit a protective mechanism by reducing the extent 
of acrolein binding to microsomal protein through binding to the 
free sulphydryl group rather than the free amino group 
(Wildenaeur & Oehlmann 1982). Severe toxicity following allyl 
alcohol intoxication in isolated rat hepatocytes is attributed to 
the formation of acrolein by the action of alcohol dehydrogenase, 
this toxicity is associated with depletion of glutathione (Rikans 
& Hornbrook 1986).
The mechanisms underlying cyclophosphamide induced cytotoxicity 
remain unclear since other metabolites may produce harmful 
effects and the existence of other target sites, more crucial to 
cell survival, cannot be discounted. Acrolein binding to the 
cytoskeletal protein spectrin has been reported with possible 
consequences of great importance for cell viability and various 
transmembrane processes which depend on an intact cytoskeleton 
(Wildenaeur & Oehlmann 1982).
The response of human hepatocyte cultures to cyclophosphamide 
was broadly similar to that observed for rat hepatocytes 
suggesting that biotransformation of cyclophosphamide may occur 
to a comparable J extent. However, a great deal more data on 
human hepatocytes is required in order to effect a meaningful 
comparison.
Rat Hepatocyte Monolayer Cultures, Cytotoxicity of 2-4 
Dinitrophenol
Leakage of LDH (Fig 53a) increased in a dose dependant manner, 
exposure to 1000 pg/ml (5.4 m M ) producing a significant increase
Fig 53 Exposure of Rat Hepatocyte Monolayer
Cultures to 2-A Dinitrophenol, LDH leakage 
and Protein Synthesis
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Fig 55 Exposure of Rat Hepatocyte Monolayer
Cultures to 2-4 Dinitrophenol; ECOD Activity
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Incorporation of radiolabel (Fig 53b) did not appear to be 
significantly inhibited although a slight decrease was observed 
following a 2 4 hour exposure to 100 and 1000 pg/ml.
Cellular ATP levels exhibited a rapid decrease (Fig 54a) 
following a 2 hour exposure to 100 and 1000 pg/ml, 10 jag/ml 
resulting in a more gradual decrease. The decline in ATP/ADP 
ratio (Fig 54c) broadly paralleled the response observed in ATP 
levels .
Control glutathione levels were inconsistent with other control 
values and hence no conclusions can be made. ECOD activity was 
significantly inhibited at all 3 dose levels following a 24 hour 
exposure, the degree of inhibition progressively increasing with 
exposure time (Fig 55). A slight decrease in conjugation with 
sulphate compared to glucuronide conjugation was apparent 
following a 2 hour exposure but not at later times (Fig 56).
Discussion
2-4 Dinitrophenol, originally intended as a slimming agent, is 
currently used in the manufacture of dyes, as a wood preservative 
and as an insecticide. However, in addition to weight loss, it 
also produces uncontrollable hypernea and hyperthermia, death 
frequently ensues. These effects are each related to its 
well-documented action as an uncoupler of oxidative 
phosphorylation. The exact mechanism involved is not fully 
elucidated although the metabolic state produced by 2-4 
dinitrophenol is characterised by an increased rate of oxygen 
uptake, loss of the pH gradient across the inner mitochondrial 
membrane and an increase in ATP hydrolysing activity. 
Perturbations in other mitochondrial functions are also evident, 
including prevention of Ca^+ accumulation (George et al 1 982), K"*" 
efflux and activation of phospholipase activity (Knowles 1982) 
and lipid metabolism (Kilworth et al 1984).
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An immediate decrease in the energy status of the liver occurs 
following administration of 2-4 dinitrophenol to rats (Cunningham 
et al 1986). 2-4 Dinitrophenol per se is a mitochondrial
uncoupler. In man and experimental animals it undergoes 
metabolism in the liver involving sulphate and glucuronide 
conjugation (Fig 57). However, nitro reduction has been noted 
both in vivo and in vitro (Eiseman et al 1974; Parker 1952) 
occuring in cytosolic and microsomal fractions.
Fig 57 Postulated Metabolic Pathways of 2-4 
Dinitrophenol
OH
Sulphate and Glucuronide 
Conjugation
NO.
Nitro Reduction
2 amino 4nitrophenol 4 amino 2nitrophenol
2.4 diaminophenol
Cytotoxicity, involving an increase in leakage of LDH following 
exposure to 2-4 dinitrophenol, has been observed by other 
research groups (George et al 1982). These authors also reported 
extensive damage to mitochondria. Incorporation of radiolabel 
did not appear directly associated with the decline in ATP 
levels. This is in contrast with the amino acid analogue 
ethionine which rapidly depletes hepatic ATP levels and results 
in a reduction in protein synthesis.
-  84  -
The decrease in ATP levels and energy status of the cells is in 
general agreement with in vivo data (Cunninghan et al 1986) and 
is similar to other results involving rat hepatocyte cultures 
(George et al 1982). These authors, together with Wiebkin et al
(1979), also demonstrated a decrease in ATP levels after a 10-20 
minute exposure. The time delay -in the response at the lowest 
dose level may reflect the presence of serum in the culture 
system and the possible influence of protein binding on 
subsequent cytotoxicity. 2-4 Dinitrophenol is reported to bind 
strongly to plasma proteins (Cheeseman 1984).
The moderately rapid inhibition of ECOD activity may involve a 
perturbation of NADPH levels rather than a direct action on 
cytochrome P450 (Wiebkin et al 1979). A marked reduction in the 
formation of conjugation products from phase I metabolites is 
also reported. This was not evident at later time points in this 
culture system which may reflect prior interference with phase I 
metabolism. The decrease in conjugation capacity is thought to 
result from the very rapid and severe depletion of ATP levels and 
the subsequent impairment of synthesis of activated sulphate and 
glucuronide, which precedes inhibition of mixed function oxidase 
activity.
Cellular ATP levels appear to be a sensitive indicator of 2-4 
dinitrophenol intoxication, consistent with impairment of 
mitochondrial function being involved in the cytotoxic response. 
However, it is unclear if this is the sole critical target site 
or whether other important organelle/Cytosol ATP dependant 
gradients, such as Ca^+ homeostasis (Acosta & Sorenson 1983), are 
involved.
Rat Hepatocyte Monolayer Cultures, Cytoxicity of Thioacetamide
An increase in leakage of LDH was evident at 1000 ^g/ml (1.3 x 
10“  ^ M) following a 2 hour exposure (Fig 58a). Incorporation of 
radiolabel appeared to be inhibited in a dose related manner, a
Fig 58 Exposure of Rat Hepatocyte Monolayer
Cultures to Thioacetamide, LDH leakage
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Fig 60 Exposure of Rat Hepatocyte Monolayer
Cultures to Thioacetamide, Glutathione 
and ECOD Activity
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Fig 61 Exposure of Rat Hepatocyte Monolayer
Cultures to Thioacetamide; ECOD Activity
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2 4 hour exposure to 1000 pg/ml causing a significant decrease 
(Fig 58b).
Lowered cellular ATP levels (Fig 59a) were associated with 
cytotoxicity, the ATP/ADP ratio (Fig 59c) exhibiting a time and 
dose dependant decrease. Hepatocyte glutathione levels (Fig 60a) 
were unaltered at non-cytotoxic concentrations.
ECOD activity (Fig 60b) was inhibited in a dose related fashion 
following a 96 hour exposure. Inhibition of sulphate conjugation 
activity appeared to be slightly greater than that of glucuronide 
conjugation (Fig 61).
Discussion
Thioacetamide is commonly utilised industrially in chemical 
synthesis as a source of hydrogen sulphide and in biological 
research because it impairs the synthesis of messenger and 
transfer RNA. It was also introduced in 1945 as an agent to 
retard the decay of oranges.
Thioacetamide is a well known hepatotoxin and hepatocarcinogen 
producing centrilobular hepatic necrosis. Metabolic activation 
to a reactive intermediate is generally accepted as a 
prerequisite to development of hepatic damage (Hunter et al 1977; 
Porter et al 1979). In addition, thioacetamide is employed as a 
model for inducing liver cirrhosis following chronic oral 
administration, subsequent bile duct proliferation and liver 
tumours are well documented (Fitzhurgh & Nelson 1948; Gupta 1956; 
Becker 1983).
Thioacetamide and its S-oxide both require metabolic activation 
to an active species, this metabolism (Fig 62) occuring rapidly 
in the liver (Porter et al 1979). Hepatic necrosis is correlated 
with the extent of covalent binding, an amino acid adduct (N - 
acetyl lysine) appearing to arise from a common intermediate 
which, after subsequent attack by water, leads to the formation
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of acetamide (Dyroff & Neal 1983). Acetamide Is relatively 
nontoxic and does not possess the cytotoxic properties of either 
thioacetamide or its S-oxide.
Fig 62 Postulated Metabolic Pathways of 
Thioacetamide
MFOMFC
covalent binding 
cytotoxity
2 -
acetamide sulphate
1. thioacetamide, 2. thioacetamide s-oxide,
3. thioacetamide s-dioxide, MFO mixed function 
oxidase activity
(Modified from Hunter et al 1977 and Dryoff 
& Neal 1983)
Controversy surrounds the microsomal enzyme system responsible 
for activation of thioacetamide to a toxic species. Microsomal 
flavin containing monooxygenases (FADM) are thought to be 
primarily responsible for the activation of both thioacetamide
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(De Ferreyra et al 1983) and thioacetamide S-oxide (Chieli & 
Malvaldi 1984). Hepatic necrosis appears to be reduced by the 
presence of competitive inhibitors of FADM activity, such as 
chlorpromazine or methimazole, and seems not to be affected to 
the same extent by typical inducers or inhibitors of cytochrome 
P450, as described by Hunter et al (1977).
The cytotoxic response observed in this hepatocyte culture system 
presumably reflects the sharp increase in serum enzyme levels 
associated with centrilobular necrosis following acute 
thioacetamide intoxication in rats (Trennery & Waring 1983).
These authors also report progressive ultras truetural damage to 
the endoplasmic reticulum which may partially account for the 
observed inhibition of protein synthesis and ECOD activity in 
culture.
The progressive decrease in ATP levels and ATP/ADP ratio was 
indicative of a perturbation of the cellular energy status. An 
inhibition of carbamoyl phosphate synthesis associated with in 
vivo thioacetamide induced liver damage is thought to reflect low 
cellular ATP levels (Trennery & Waring 1983). Structural and 
functional abberations of liver mitochondria, which were 
reversible on cessation of exposure, are reported in vivo 
following chronic thioacetamide administration to rats (Moller & 
Dargel 1984). These authors also report a perturbation of 
mitochondrial Ca^+ uptake and retention times and marked changes 
in the fluidity of the mitochondrial membrane.
A decrease in hepatic cytochrome P450 content and associated 
metabolic activity is noted in vivo following thioacetamide 
administration to rats (Hunter et al 1977). The delayed 
inhibition of monooxygenase activity in this culture system is 
suggestive of a prior depletion of cellular reduced cofactor 
levels rather than a direct action of a reactive metabolite.
Hepatocyte glutathione did not appear to play a protective role 
in thioacetamide intoxication. This is in accordance with the in
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vivo situation (Trennery & Waring 1983). Moreover, glutathione 
did not reduce the extent of covalent binding associated with the 
metabolism of thioacetamide S-oxide in vitro (Dyroff & Neal 
1983).
The ATP/ADP ratio appears to be a sensitive indicator of a 
perturbation of hepatocyte biochemical function, possibly 
reflecting damage to the inner mitochondrial membrane. However, 
the key initiating factors in thioacetamide induced cell necrosis 
and the stage at which alterations in the cellular energy status 
become indicative of impending cell death remain, as yet, 
unresolved.
Rat Hepatocyte Monolayer Cultures, Cytotoxicity of Ethylene 
Dibromide
Leakage of LDH (Fig 63a) was significantly increased following a 
2 hour exposure to 0.05 and 0.5 pg/ml (2.7 x 10“  ^ M) ethylene 
dibromide. Incorporation of radiolabel (Fig 63b) was impaired in 
a dose dependant manner after a 24 hour exposure, more than 50% 
inhibition occuring at 0.05 jjg/ml.
Lowered cellular ATP levels (Fig 64a) were associated with 
cytotoxicity and a significant decrease was also apparent 
following a 96 hour exposure to 0.005 ^g/ml. The decline in 
ATP/ADP ratio paralleled the decrease in ATP content (Fig 64c).
Hepatocyte glutathione content (Fig 65a) was severely depleted at 
cytotoxic concentrations, exposure to 0.005 jig/ml causing a more 
gradual decrease. ECOD activity (Fig 65b) was markedly inhibited 
at cytotoxic dose levels; activity was also impaired following 
exposure to 0.005 pg/ml. Conjugation with glucuronide and 
sulphate did not appear to be significantly altered (Fig 66).
Fig 63 Exposure of Rat Hepatocyte Monolayer
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Fig 65 Exposure of Rat Hepatocyte Monolayer
Cultures to Ethylene Dibromlde, Glutathione
and ECOD Activity
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Fig 66 Exposure of Rat Hepatocyte Monolayer
Cultures to Ethylene Dibromide; ECOD Activity
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Discussion
Ethylene dibromide is widely used as a soil fumigant for a 
variety of vegetable, fruit and grain crops, although it is 
primarily utilised as a lead scavenger in anti-knock petrol. It 
is also employed as an intermediate in the synthesis of numerous 
dyes and pharmaceuticals, and as a solvent for various resins.
Thé major metabolite of ethylene dibromide formed in vivo is a 
mercapturic acid derivative thought to arise via 2 different 
pathways (Fig 67). These each involve formation of a potentially 
toxic intermediate (Van Bladeren et al 1981a; Hill et al 1978).
Fig 67 Postulated Metabolic Pathways of 
Ethylene Dibromide
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Conjugation of ethylene dibromide with glutathione forms S-2 
bromoethyl glutathione in which the halogen atom is highly 
activated by the neighbouring sulphur atom (Van Bladeren et al 
1981b). Reaction of a second molecule of glutathione with the 
sulphur atom of the glutathione conjugate leads to formation of 
ethylene (Fig 67). The oxidative and conjugative pathways occur 
in a ratio of 4:1 in rats (Van Bladeren et al 1981a) and 
metabolism in isolated rat hepatocytes closely resembles that in 
vivo (Sundheimer et al 1982).
Cent rilobular necrosis is reported following ethylene dibromide 
intoxication in man and experimental animals (Broda et al 1976). 
Liver injury is associated with covalent binding to cellular 
macromolecules (Hill et al 1978) and depletion of glutathione 
content (Botti et al 1982; Kluwe et al 1981). Recent evidence 
indicates that S-2 bromoethyl glutathione is probably the 
reactive metabolite responsible for the mutagenic and 
carcinogenic activity of ethylene dibromide (Inskeep & Cuengerich 
1984; Sundheimer et al 1982). Cenotoxicity and cytotoxicity do 
not appear associated either in vivo (Storer & Connolly 1983) or 
in vitro (Brimer et al 1982). Bromoacetaldehyde is reported to 
bind preferentially to microsomal protein (Shih & Hill 1981).
A similar cytotoxic response, involving a rapid increase in LDH 
leakage, was reported in isolated rat hepatocytes exposed to 
ethylene dibromide (Albano et al 1984). Elevated serum liver 
enzyme levels are also associated with ethylene dibromide 
intoxication in rats (Botti et al 1986). While a direct action 
on plasma membrane integrity may explain the rapid efflux of 
cytosolic enzymes, other biochemical parameters also indicate a 
marked disturbance of hepatocyte functional integrity.
Inhibition of protein synthesis may reflect damage to the 
endoplasmic reticulum involving binding of bromoacetaldehyde to 
microsomal proteins. The response of hepatocyte glutathione and 
ATP levels was broadly similar indicating that glutathione exerts 
a protective influence. Perturbation of mitochondrial function
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may be involved in ethylene dibromide cytotoxicity. The severe 
depletion of glutathione occuring at cytotoxic concentrations 
suggests a perturbation of the mitochondrial pool of glutathione 
as well as the cytosolic pool. Mitochondrial glutathione levels 
are reported to be intimately associated with mitochondrial 
integrity.
Hepatic mitochondrial injury is reported in vivo following 
exposure to ethylene dibromide. This is associated with 
depletion of mitochondrial glutathione levels (Botti et al 1986). 
Neither of the glutathione depleting agents, diethylmaleate or 
1,3 bis(2-chloroethyl) 1-nitrosourea - the latter penetrating the
mitochondrial membrane - deplete mitochondrial glutathione. The 
response appears to be the result of a direct action of ethylene 
dibromide on mithochondrial glutathione but the exact mechanism 
remains unclear. It may involve either conjugation with a 
mitochondrial glutathione-S transferase, the existence of which 
has been questioned, or lipid peroxidation. Initial studies, 
however, did not reveal any significant peroxidative activity 
(Botti et al 1986). In contrast, induction of lipid 
peroxidation, as well as an increase in covalent binding, was 
associated with depletion of glutathione levels by ethylene 
dibromide in isolated rat hepatocytes (Albano et al 1984).
The rapid inhibition of ECOD activity, which was apparent at non 
cytotoxic concentrations, suggests that the endoplasmic reticulum 
may be a critical target site. Liver injury in vivo is reported 
to be associated with a dramatic reduction in cytochrome P450 
content and the amount of bromoacetaldehyde formed (Van Bladeren 
et al 1981a). This, presumably, reflects covalent binding of 
bromoacetaldehyde to microsomal protein (Sundheimer et al 1982), 
possibly involving various sites on the cytochrome P450 
apoprotein. The ECOD activity was, ostensibly, a sensitive 
indicator of a perturbation of hepatocyte metabolic competence by 
ethylene dibromide, glutathione appearing to play a protective 
role .
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Rat Hepatocyte Monolayer Cultures, Cytotoxicity of 
Bromobenzene
Leakage of LDH was significantly increased following exposure to 
5.0 pg/ml (3.2 X 10 M), no cytotoxic response was apparent at 
lower concentrations (Fig 68a). Incorporation of radiolabel 
(Fig 68b) exhibited a dose dependant inhibition, levels were only 
significant at 5.0 jig/ml.
Cellular ATP content (Fig 69a) also decreased in a dose related 
manner, a 2 4 hour exposure to 0.5 pg/ml eliciting a significant 
response. The ATP/ADP ratio reflected the decline in ATP levels 
(Fig 69c).
Lowered glutathione levels were associated with cytotoxicity,
(Fig 70a). ECOD activity was markedly inhibited at cytotoxic 
concentrations, a gradual progressive inhibition was apparent at 
non cytotoxic dose levels (Fig 70b). No specific response in 
either sulphate or glucuronide conjugation was observed (Fig 7 1).
Discussion
Bromobenzene is primarily utilised in organic synthesis, as a 
solvent for large scale crystallisations and as an additive in 
motor oils.
It is well established that bromobenzene-induced hepatotoxicit y 
is mediated by reactive metabolites which are formed by the 
cytochrome P450 mixed function oxidase system (Fig 72), and that 
hepatic glutathione acts in a protective manner (Jollow et al 
1974; Gillette et al 1974).
Centrilobular necrosis occurs following bromobenzene
intoxication, the severity of hepatic injury appears to be
associated with the extent of covalent binding and depletion of
glutathione levels (Brodie et al 1971; Gillette et al 1974). The
Fig 68 Exposure of Rat Hepatocyte Monolayer
Cultures to Bromobenzene, LDH
Leakage and Protein Synthesis
a ) LDH leakage
300--
24 962
Exposure Time (hours)
b) Protein Synthesis
100-r
60 - -
T
O 40--
20- -
2 24 96
Exposure Time (hours)
0.05 pg/ml
0.5 pg/ml
5.0 pg/ml (0.3 mM)
Results are mean iSEM of 3 
replicate samples. 
Significantly different from 
control levels, *p < 0.05
**p < 0.0 1.
Fig 69 Exposure of Rat Hepatocyte Monolayer Cultures
to Bromobenzene; ATP, ADP and ATP/ADP Ratio
ATP
100-r
80 - -
40--
2 24
ADP
Ratio
24
Exposure Time (hours)
200-h
100- X.
24a 96
100- r *
80--
p 60 —
Ü 40--
X
20 —
96
• 0.05 jug/ml
X 0.5 pg/ml
+ 5.0 jug/ml (0.3 mM )
Results are mean ISEM of 3 
replicate samples. 
Significantly different from 
control levels, *p < 0.05,
**p < 0.01.
Fig TO Exposure of Rat Hepatocyte Monolayer
Cultures to Bromobenzene, Glutathione
and ECOD Activity
a ) GSH content
80--
20- -
2 24 96
Exposure Time (hours)
b) ECOD activity
100 -f-"
80--
f-i 60 - -
40--
20- -
242 96
Exposure Time (hours)
• 0.05 pg/ml
X 0.5 pg/ml
+ 5.0 jjg/ml (0.3 mM)
Results are mean ±SEM of 3 
replicate samples. 
Significantly different from 
control levels, *p < 0.05
**p < 0.01.
Fig 71 Exposure of Rat Hepatocyte Monolayer
Cultures to Bromobenzene; ECOD Activity
□  sulphate conjugation products 
g  glucuronide conjugation products 
g  free 7 hydroxycoumarin
* sulphate ; glucuronide ratio
2 4
Results are mean iSEM of 3 replicate samples. 
*
12-p
2 3
10:' 2 2
S e -
\  7-
5-
•H
•H
0-8
AS CB
2 3
2*3
2 1
S A B C
2 1
1 4
s A B C
24 96
Exposure Time (hours)
S - solvent control cultures, A - 0.05 jig/ml, 
B - 0.5 pg/ml, C - 5.0 pg/ml
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Fig 72 Postulated Metabolic Pathways of Bromobenzene
Bromobenzene
MFO
NADPH
Or
covalent binding covalent binding
2,3 epoxide 3,4 epoxide
Br
Glutathione
Gonjuqation
,OH
OH
p—bromophenoio-bromophenol
mercapturic acid 
derivatives
Br
,0H 3,4 dihydrodiol
/OHOH
(From Jollow et al 1974)
2.3- and 3,4-epoxides (Fig 72) are implicated as the reactive 
metabolites responsible for hepatotoxicity; current evidence 
favouring the 3,4-epoxide as the major cytotoxic agent. 
Pretreatment with phénobarbital, which preferentially induces^
3.4-epoxide pathway, increases the severity of liver necrosis. 
In contrast, 3-methylcholanthrene pretreatment, which induces 
formation of the 2,3-epoxide, does not alter the extent of 
hepatic injury (Reid et al 1971). The 3,4-epoxide is also 
reported to rapidly bind to microsomal protein, whereas the 
2,3-epoxide appears more stable and may be detoxified by 
conjugation in the cytosol (Lau & Zannoni 1981).
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Cytotoxicity in rat hepatocyte monolayer cultures and suspension 
cultures, following exposure to bromobenzene, has also been 
reported by Gottschall et al (1983), Casini et al (1982) and Thor 
et al (1978). The latter two authors reported a cytotoxic 
response only at tenfold higher concentrations to those employed 
here, and in hepatocytes from phénobarbital treated rats.
However, Goethals et al (1984) and Gottschall et al (1983) 
observed a cytotoxic response in non-induced rat hepatocytes at 
similar concentrations to those utilised here. Differences in 
animal strain and incubation conditions may account for the 
variation in potency.
A rapid inhibition of protein synthesis associated with 
cytotoxicity has been reported in isolated rat hepatocytes, and 
bromobenzene exposure also appears to reduce the incorporation of 
leucine into cellular macromolecules before histological 
evidence of necrosis (Reid & Krishna 1973). Contributary factors 
to this response in protein synthesis may be an impairment of 
amino acid uptake (Thor et al 1979) and/or covalent binding of 
the 3,4-epoxide to endoplasmic reticulum proteins.
The decline in ATP levels did not ostensibly reflect an early 
critical event in bromobenzene intoxication. Thor and Orrenius
(1980) suggested that loss of ATP was a late event and that 
perturbations in cellular integrity were only evident following 
glutathione depletion and phénobarbital induction.
In this culture system lowered glutathione levels were associated 
with cytotoxicity indicating that glutathione may play a 
protective role as reported in vivo (Jollow et al 1974). Lipid 
peroxidation has also been implicated in bromobenzene induced 
toxicity in hepatocyte cultures (Casini et al 1982). These 
authors did not regard lipid peroxidation as the sole cause of 
cell death and suggested that a second mechanism was involved 
which was related to the extent of covalent binding.
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ECOD activity was markedly impaired at cytotoxic dose levels, a 
decrease in cytochrome P450 content is also evident in mice 
exposed to bromobenzene (Funck-Brentano et al 1984). These 
authors suggested that loss of activity was due to covalent 
binding of reactive metabolites to various sites on the 
apoprotein. This may involve the 3,4-epoxide which is reported 
to preferentially bind to histidine residues of microsomal 
proteins (Lau & Zannoni 1981). The decrease in ECOD activity at 
non-cytotoxic concentrations probably involves a prior depletion 
of cellular NADPH levels (Thor & Orrenius 1980).
No single parameter appeared to be a sensitive indicator of a 
perturbation in hepatocyte biochemical function although the 
observed response in protein synthesis and ECOD activity indicate 
the endoplasmic reticulum as a possible target site. A direct 
action on plasma membrane structural and functional integrity has 
also been put forward as a possible target site for bromobenzene 
metabolites (Thor & Orrenius 1980).
CHAPTER IX
GENERAL DISCUSSION AND CONCLUSIONS
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General Discussion
In vitro studies i n v ol ving isolated ma m m a l i a n  cells are rapidly 
becoming an important altern ative to whole animal 
experimenta ti on. M a i n t e n a n c e  of several critical metabo li c 
functions is g e n e r a l l y  regarded as an essent ial requisite for 
cells if they are to be utilised in toxicity testing. H e p a to cy te 
stru ct ural and f u n c t i o n a l  competence has been c h ar ac terised  in 
rat and human short term mo nol aye r culture f o l l owing isola tion 
using a ver sati le  biopsy perfusio n technique.
Hepatocyte monolayer cultures may be regarded as more reliable 
for the prediction of toxic events in vivo than other established 
cell lines, despite the well documented changes occuring in 
hepatocyte cytochrome P450 levels in culture. The data obtained 
in this hepatocyte culture system strongly suggests retention of 
sufficient cytochrome P450 monooxygenase activity to activate 
certain chemicals to their respective reactive metabolite(s ). It 
also, presumably, reflects to some extent the in vivo balance of 
substrate activation and detoxification processes as well as 
incorporating various cellular repair mechanisms.
In general, the toxic response elicited in this hepatocyte 
culture system was in agreement with reported in vivo data. 
However, comparison of in vivo data with in vitro data is rarely 
straightforward, a much more diverse choice of indicators of a 
perturbation in cellular integrity exists for in vitro 
investigations. Comparison is further compounded by 
pharmacokinetic, extra-hepatic and other factors which may 
influence the in vivo response and the selection of appropriate 
end points which are often related to convenience of measurement. 
In addition, circulating levels of test chemicals are often not 
reported; the use of single or repeated dose levels and the time 
points of assay also complicate the issue. With regard to early 
events in cytotoxic processes, the sensitivity and accuracy of 
biochemical indicators are greatly influenced by the large amount 
of unaffected tissue in the intact animal. However, where
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applicable a comparison with reported in vivo data has been 
attempted for results obtained in this hepatocyte monolayer 
system (Table 4). Use of the most sensitive indicator in culture 
of a perturbation in hepatocyte biochemical integrity was not 
possible for all of the chemicals since relevant in vivo data was 
limited.
The capacity of hepatocytes to retain cytosolic enzymes is 
generally accepted as an indicator of irreversible damage to the 
plasma membrane. One advantage is that it can be measured both 
in vivo and in vitro as an indication of a,toxic insult and, 
therefore, is included where applicable in table 4. Unless the 
plasma membrane is the site of toxic damage, loss of membrane 
integrity is almost invariably preceded by subcellular changes 
which may provide important information on possible mechanisms of 
action and potential target sites.
A decrease in cellular ATP/ADP ratio appeared to be a sensitive 
indicator of a perturbation in hepatocyte biochemical integrity 
following exposure to either paracetamol or thioacetamide. This 
gives a preliminary indication of mitochondrial dysfunction 
which, in the case of thioacetamide, is reported in vivo 
following chronic exposure. However, this in vivo response was . 
reversible upon cessation of treatment. ATP is synthesised 
mainly in the mitochondria but the contributions of cytosolic 
components to the total cellular energy status are substantial. 
Although the two components are, ostensibly, intimately related, 
extramitochondrial factors are also involved in regulation of the 
ratio. This suggests a need for caution in interpreting changes 
in this parameter purely as a result of a direct action of a 
chemical on mitochondrial integrity. Analagous to the in vivo 
situation, toxicity was only apparent following exposure to high 
doses of paracetamol and was associated with depletion of 
cellular glutathione levels.
No evidence of hepatotoxicity is apparent following in vivo 
exposure to cyclophosphamide which may reflect the rapid
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metabolism and disposition of cyclophosphamide and its 
metabolites in vivo. Any response in the liver may be relatively 
minor in comparison to the toxic damage elicited in the bladder, 
however, depression of cytochrome P450 activity occurs in vivo as 
well as in vitro.
Dinitrophenol, both in vivo and in vitro, produces a severe 
depletion of ATP levels presumably as a result of uncoupling of 
oxidative phosphorylation. The decrease in protein synthesis and 
cytochrome P450 activity probably reflects the numerous 
consequences of extremely low cellular ATP levels.
Cytotoxicity, following in vivo or in vitro exposure to either 
ethylene dibromide or bromobenzene, appears to be associated with 
lowered cellular glutathione levels. The depletion of 
glutathione following exposure to ethylene dibromide is also 
indicative of a perturbation of mitochondrial glutathione and 
integrity which also occurs following in vivo exposure.
The endoplasmic reticulum may be a target site following exposure 
of hepatocytes to ethylene dibromide, cyclophosphamide, 
thioacetamide or bromobenzene. This tentative proposal is 
prompted by the inhibition of protein synthesis and cytochrome 
P450 activity. However, the processes contributing to their 
respective activities are complex and not properly elucidated. 
Thus, inhibition may well result from other defective cellular 
functions, reflective of other possible target sites.
No single parameter was indicative of a perturbation of cellular 
integrity following exposure to all six chemicals. The relative 
importance of early changes in biochemical function appeared to 
vary from chemical to chemical, suggesting that chemical induced 
toxicity may involve a number of interrelated events. A more 
comprehensive approach combining transmission electron microsopy, 
cytochemical and biochemical indicators may further elucidate 
possible target sites and their relative contribution to cell 
death. However, evaluation of several biochemical parameters
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appears to be a more appropriate assay of a perturbation in 
cellular integrity.
The use of cells isolated from human tissues now permits a direct 
evaluation of toxicological studies which were previously based 
solely on non-human animal experimentation. Cultured human 
hepatocytes appear to de-differentiate far more slowly in culture 
than their rat counterparts and, more importantly, cytochrome 
P450 levels appear to be much more stable. The utility of 
hepatocyte cultures as a model system for chemical induced 
cytotoxicity studies largely depends upon the metabolic 
competence maintained by the cells. As a result, human 
hepatocyte cultures are potentially extremely useful for in vitro 
toxicological studies. Comparative analysis of xenobiotic 
metabolism and cytotoxicity data between cells isolated from 
laboratory animals and humans may indicate the most appropriate 
species to employ in vivo. In addition, studies involving human 
hepatocytes may also provide valuable information towards risk 
assessment in vivo for numerous chemicals which,because of 
ethical considerations, can only be assessed in human tissue by 
in vitro techniques. This potential is emphasised by the 
correlation between data obtained in this rat hepatocyte culture 
system and reported in vivo responses.
The possibility of large inter-individual variations in 
xenobiotic metabolism and cytotoxic response in hepatocytes 
isolated from different human donors should be taken into 
account, since these may be of the same magnitude as those 
occuring between laboratory animal species. This highlights the 
requirement for the reproducibility and reliability of such model 
systems to be characterised and established, thus allowing 
reliable toxicological evaluation of the data.
Storage of rat liver tissue prior to hepatocyte isoation revealed 
that perfusion should commence within 4 hours of liver excision 
for obtainment of optimal yields. Other simple storage 
procedures proved unsatisfactory with regard to successful
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hepatocyte isolation. Human hepatocyte yields may be improved by 
either shortening the delay between liver resection and perfusion 
or further refinement of the perfusion method.
The main mechanisms involved with cryogenic survival of rat • 
hepatocytes are the formation of intracellular ice, physical 
osmotic stress and osmotically induced toxic solute 
concentrations. These factors appear intimately associated with 
the rate of cooling. A cooling rate faster than the generally 
employed l°C/min seemed to result in optimal survival of rat 
hepatocytes, other contributing factors in the cryopreservation 
scheme presumably minimising the extent of cellular damage. 
Post-thaw handling of hepatocytes also appeared to influence 
subsequent cell survival in culture suggesting that such 
procedures should not be overlooked in a successful 
cryopreservation protocol.
Future improvements may result from a more solid scientific 
understanding of the ways in which critical physical conditions 
permit cell survival as well as the inter-relationship between 
basic physical processes - such as ice crystal formation and ' 
osmotic permeability of biological membranes - and their 
modification by cryoprotective agents. One alternative approach, 
involving a supercooling technique in the absence of the physical 
stress imposed by freezing, may allow short term storage of 
hepatocytes. This would be of considerable value regarding 
maximal use of human hepatocytes.
Survival of human hepatocytes following cryopreservation was 
similar to that of rat hepatocytes. The improved quality of rat 
hepatocyte cultures following cryopreservation and Percoll 
density gradient centrifugation, in view of the apparent greater 
stability of cytochrome P450 in human hepatocytes, is 
encouraging. This may permit establishment of a bank of 
cryopreserved human hepatocytes from many individuals and the use 
of such cells in short term in vitro cytotoxicity assays.
CHAPTER X
REFERENCES
- 10 1 -
Acosta D, Anuforo DC, Smith RV (1980); Tox. Appl. Pharmacol. 5 3 , 
306-314.
Acosta D & Mitchell DB, (1981); Biochem. Pharmacol. 3225-
3230.
Acosta D & Sorensen EMB (1983); Ann. NY. Acad. Sci. 407,
78-93.
Albano E, Poli G, Tomasi A, et al (1984); Chem. Biol. Interact. 
50 225-265. '
Ashwood-Smith MJ (1980); in Ashwood-Smith M J , Farrant J (ed).
Low Temperature Preservation in Medicine and Biology, pp 19-44.
Autrup H (1980); in Horriss C C , Trump BF, Stoner CD (ed).
Methods in Cell Biology, £2» PP 385-401.
Ballet F , Bouma M-E, Wang S-R et al (1 984); Hepatology _4, 
849-854.
Balls M & Clothier R (1983); Acta. Pharmacol. Toxicol. 52 , 
115-137.
Barrett LA, McDowell EM, Frank A L et al ( 1 976); Cancer Res. 3 6 ,
1003-1010.
Bates DJ, Foster A B , Jarman M (1981); Biochem, Pharmacol. 30, 
3055-3065.
Baur H, Kasperek S, Pfaff E (1975); HSZ Physiol. Chem. 356, 827. 
Becker FF (1983); JNCI TJ, 531-558.
Begue JM, Le Bigot JF, Guguen-Guillouzo C et al (1983); Biochem. 
Pharmacol. 32, 1643-1646.
- 102 -
Begue JM, Guguen-Guillouzo, Paseloup N et al (1984); Hepatology 
4, 839-842.
Belleman P, Gebhardt R, Mecke D (1977); Anal. Biochem. 8 1 , 
408-415.
Belleman P, Upovsky KU, Kummer D ( 1979); 7th Intern. Congress 
Pharmacol., 397.
Bergmeyer HU (1974); in Methods of Enzymatic Analysis, 2 ,  
pp 574 .
Bernaert D, Wanson JC, Mosselmans R et al ( 1 979); Biol. Cell 34 , 
159-174.
Berry MN & Friend DS (1969); J Cell. Biol. 43, 506-520.
Bio. Rad. Protein Assay (1981); Bio-Rad Laboratories, Caxton Way, 
Watford, Herts.
Bissell DM (1982); in Isolation, Characterisation and Use of 
Hepatocytes. Harris RA & Cornell NW (ed), pp 51-58.
Bissel DM & Tilles JG (1971); J Cell. Biol. 50, 222-231.
Bissel DM, Hammaker LE, Walker PR et al (1 973); J Cell. Biol. 59 , 
722-734.
Bissell DM, Hammaker LE, Meyer UA (1974); J Cell. Biol. 59 , 
735-747.
Boobis AR, Tee LB, Hampden CE et al (1986); Ed. Chem. Tox. 2 4 , 
731-736.
Botti B, Moslen M T , Trieff NM et al (1982); Chem. Biol. Interact. 
42, 259-270.
103 -
Botti B, Bini A, Calligaro A et al (1986); Tox. App. Pharmacol. 
_83, 494-505.
Bridges JW, Benford DJ, Hubbard SA (1982); in Animals in 
Scientific Research, an Effective Substitute for Man, Turner P 
(ed). pp 47-68.
Bridges JW, Benford DJ, Hubbard SA (1983); Ann. NY Acad. Sci. 
407, 42-63.
Brimer PA, Tan E-L, Hsie AW (1982); Mut. Res. 95, 377-388.
Broda C, Nachtomi E, Alumot E (1976); Gen. Pharmacol. _7> 344-358
Brodie BB, Reid WD, Cho AK et al (1971); Proc. Natl. Acad. Sci. 
USA 68, 146-160.
Butterworth BE, Bermudez E, Smith-Oliver T et al (1984); 
Carcinogenesis 5 ,  1329-1336.
Byard JL, Reese J A , Knadle SA (1982); in Isolation, 
Characterisation and Use of Hepatocytes, Harris RA & Cornell NW 
(ed). pp 69-76.
Cage JC (1953); Biochem. J 426.
Capelle P, Dhumeaux D, Mora M et al ( 1 972); Gut _1_3 , 366.
Casini A, Giroli M, Hyland J, et al (1982); J Biol. Chem. 257, 
6721-6728.
Chaumalaun R A , Offerjins EGJ, Bakker JC et al (1 973); in Peg DE 
(ed). Organ Preservation. pp 140-150.
Cheeseman KH (1984); Advances in Inflammation Research, _6> 
179-188.
- 104 -
Chieli E & Malvaldi G (1984); Toxicology 21* 41-52.
Clement B, Guguen-Guillouzo C, Campion J-P et al (1984); 
Hepatology _4» 373-38 1
Cornell NW (1982); in Characterisation, Isolation and Use of 
Hepatocytes, Harris KA & Cornell NW (ed). pp 11-20.
Coundouris J, Grant MH, Engeset J, et al (1986); 10th European 
Workshop on Drug Metabolism at University of Surrey.
Cunningham CC, Molby CR, Radda GK (1986); Biochem. Biophys. Acta 
885, 12-22.
Dalet C, Fehlmann M, Debey P (1982); Anal. Biochem. 122,
119-123.
Dauterman WC (1980); in Introduction to Biochemical Toxicology, 
Hodgson E and Guthrie FE (ed). pp 133-142.
Davis M (1982); Ad. Drug. React. Ac. Pols. Rev., 2> 1-33.
Dawson M (1982); in Animals in Scientific Research, An Effective 
Substitute for man? Turner P. (ed). pp 109-118.
Decad GM, Hsieh D H , Byard JL (1977); Biochem. Biophys. Res.
Comm., 78, 279-287.
De Ferreyra EC, De Fenos OM, Castro J A (1983 ); Toxicol. Lett. 18, 
127-131.
De Flora S (1981); Carcinogenesis 2, 283-298.
Demoise CF, Galamabos JT, Falek A (1971); Gastroenterology 60 , 
390-399.
- 105 -
Diegelmann RF (1986); in Research in Isolated and Cultured 
Hepatocytes, Guilllouzo A and Guguen-Guillouzo C (ed). 
pp 209-224
Dougherty KK, Spilman SD, Green CE, et al (1980); Biochem 
Pharmacol _29, 21 17-2124.
Dryer SE, Dryer RL, Autor AP (1980); J Biol Chem 225,
1054-1057.
Dyroff MC & Neal RA (1983); Mol. Pharmacol. 23, 219-227.
Edwards AM, Glistak ML, Lucas CM, et al (1984); Biochem. 
Pharmacol. _32» 1 537- 1546.
Eiseman JL, Gehring PJ, Gibson JE (1974); Tox. Appl. Pharmacol.
27, 140-144.
Eklow-Lastbom L, Moldeus P, Orrenius S (1986); Toxicology 42 , 
13-23.
Englemann GL, Richardson AG, Fierer JA (1985); Arch. Biochem. 
Biophys. 238, 359-367.
Fariss MW, Brown, MK, Schmitz JA, et al (1985); Tox. Appl. 
Pharmacol. 7_9, 283-296.
Farrant J ( 1 970); in Current Trends in Cryobiology, Smith AV 
(ed). pp 139-152.
Farrant J & Ashwood-Smith MJ (1980); in Low Temperature 
Preservation in Medicine and Biology, Ashwood-Smith M J , Farrant J 
(ed). pp 1-18, pp 287-310.
Fishbein WN & Stowell RE (1968); Cryobiology _4, 283.
Fitzhurgh OG & Nelson A A (1948); Science 108, 626-628.
- 10 6 -
Fowler KJ (1984); J Clin. Pathol. 37, 1191-1193.
Fritz RS, Sturapo DJ, Kletzein RF (1986); Biochem. J 237,
617-619.
Fry J R , Jones CA, Wiebkin P, et al (1976); Anal. Biochem. 7 1 ,
34 1.
Fry JR & Bridges JW (1977); Biochem. Pharmacol. 969-973.
Fry JR & Bridges JW (1979); in Reviews in Biochemical Toxicology 
Vol 1. Hodgson E, Bend JR, Philpot RM (ed). 
pp 201-249.
Fry J R , Wiebkin P, Bridges JW (1980); Biochem. Pharmacol. 2 9 , 
577-581.
Fry JR (1982a); Toxicology 1-12.
Fry JR (1982b); in The Role of Animals in Scientific Research,
Turner P (ed). pp 81-90
Fuller BJ Woods R, Howe S, et al (1980); Cryobiol. J_]_, 618.
Fuller BJ & James E (1 985); Cryo. Letters _6 , 49-56 .
Fuller BJ & De Loecker W (1985); Cryo. Letters _6 , 36 1-37 1 .
Funck-Brentano C, Tirel M, Degott C, et al (1984); Biochem. 
Pharmacol. 21 > 89-96 .
George M, Chernery RJ , Krishna G (1982); Tox. Appl. Pharmacol. 
_66, 349-360.
Gerson R J , Serroni A, Gilfor D, et al (1986); Biochem. Pharmacol 
35, 4311-4321.
- 1 0 7 -
Gillette JR, Mitchell JR, Brodie BB (1974); Ann. Rev. Pharmacol. 
24, 271-328.
Goethals F, Krack G , Deboyser D, et al (1983); Toxicol 2_6, 47-54
Goethals F , Krack G , Deboyser D, et al (1984); Fund. Appl. Tox.
4, 441-450.
Gomez-L M J , Lopez P, Castell JV ( 1 984); In Vitro 22, 826-832.
Gottschall DW, Wiley RA, Hanzlik RP (1983); Tox. A pp. Pharmacol.
69, 55-65.
Gottschall DW, Harder RR, Wiley R A , et al ( 1 984); Toxicol. 3 1 , 
251-259.
Grant M H , Melvin MAL, Shaw P, et al (1985); Febs. Lett. 190, 99- 
103.
Grant M H , Melvin WT, Burke MD (1 986a); Fd. Chem. Tox. 759-
760.
Grant MH & Hawksworth GM ( 1986b) ; F d . Chem. Tox. 22? 758.
Grant M H , Burke MD, Hawksworth GM, et al (1986c); 10th European
f
Workshop on Drug Metabolism at University of Surrey.
Grant M H , Burke M D , Hawksworth GM, et al (1987); Biochem. 
Pharmacol. 3_2» 231 1-2317 .
Green CE, Segall H J , Byard JL (1981); Tox. Appl. Pharmacol. 6 0 , 
176-185.
Green CE, Dabbs JE, Tyson CA (1983); Anal. Biochem. 129,
269-276.
- 108 -
Grisham JW, Charlton RK, Kaufman DG (1978); Environ. Health 
Persp. 25, 161-171 .
Guengerich FP (1984); Biochem. Soc. Trans. J 2 , 68-70.
Guguen C, Guillouzo A, Boisnard M, et al (1975); Biol. 
Gastroenterol. 8, 223-231.
Guguen-Guillouzo C, Marie J, Cottreau P, et al (1980); Biochem. 
Biophys. Res. Com. 21» 528-534.
Guguen-Guillouzo C, Campion JP, Brissot P, et al (1982a); Cell. 
Biol. Int. Rep. _6» 625-628.
Guguen-Guillouzo C, Baffet G , Clement B, et al (1982b); in 
Isolation Characterisation and Use of Hepatocytes, Harris RA & 
Cornell NW (ed). pp 105-110.
Guguen-Guillouzo C & Guillouzo A (1983); Mol. Cell. Biochem. 
53/54, 35-56.
Guguen-Guillouzo C, Clement B, Baffet G , et al (1983); Exp. Cell 
Res. 243, 47-54.
Guguen-Guillouzo C & Guillouzo A (1986); in Research in Isolated 
and Cultured Hepatocytes, Guillouzo A and Guguen-Guillouzo C 
(ed). pp 1-12.
Guillouzo A, Oudea P, LeGuilly Y (1972); Exp. Mol. Pathol. 16,
1-15.
Guillouzo A, Begue JM, Campion JP (1 985a); Xenobiotica 15, 
635-642.
Guillouzo A, Beaune P, Gascoin M-N, et al (1985b); Biochem. 
Pharmacol. 34, 2991-2995.
-  109 -
Guillouzo A (1986); in Research in Isolated and Cultured 
Hepatocytes, Guillouzo A & Guguen-Guillouzo C (ed). pp 313-332.
Guillouzo A, Ratanasavanh D, Chesne C, et al (1987); in Drug 
Metabolism - from Molecules to Man, Benford D J , Bridges JW & 
Gibson GG (ed). pp 423-435.
Gumucio J J , May M, Dvorak C, et al (1986); Hepatology 2»
928-932.
Gupta DN (1956); J Path. Bacteriol. 72, 4 15-426.
Gurtoo HL, Marinello A J , Struck RF, et al (1981); J Biol. Chem. 
256, 11691-11701.
Gurtoo HL, Bansal S K , Parelic Z, et al (1985); Br . J Cancer. 51, 
67-75.
Guzelian PS, Bissell DM, Meyer UA (1 977); Gastroenterology 72, 
1232-1239.
Gwynn J (1981); PhD Thesis, University of Surrey.
Hayes MA, Murray CA, Rushmore TH (1986); Tox. Appl. Pharmacol. 
85, 1-10.
Hegarty JM, Brattin W J , Recknagel RO (1984); Exp. & Mol. Pathol. 
22, 331-337.
Hill D, Shih TW, Johnston TP, et al (1978); Cancer Res. 2 2 » 2438 
2442 .
Hillman EA, Valero MG, Halter SA, et al (1983); Cancer Res. 4 3 , 
245-257.
Hinson JA, Pohl LR, Monks T J , et al (1981); Life Sciences 29 , 
107-116.
- 1 1 0 -
Hirata M, Hogberg J, Thor H, et al (1977); Acta. Pharmacol. 
Toxicol. 21» 177.
Hogberg J & Kristoferson A (1977); Eur. J Biochem. 72» 77-82.
Holme JA & Soderlund E (1986); Mutat. Res. 164, 167-175.
Horner SA, Fry JR, Clothier RM (1985); Xenobiotica J_5, 681-686.
Hsu 1C, Lipsky MM, Cole KE (1985); In Vitro 22, 154-16 1.
Hue DP, Griffith KL, McLean A EM (1 985); Biochem. Pharmacol. 34 , 
4341-4344.
Hue L & Girard J (1986); in Research in Isolated and Cultured 
Hepatocytes, Guillouzo A & Guguen-Guillouzo C (ed). pp 63-86.
Hunter AL , Holscher MA, Neal RA (1 977); J Pharmacol. Exp. Ther. 
200 , 439-448.
lARC Monograph (1981); _26, 165.
Ichihara A, Nakamura T, Noda C, et al (1986); in Research in 
Isolated and Cultured Hepatocytes, Guillouzo A & Guguen-Guillouzo 
C (ed). pp 187-208.
Inmon J, Stead A, Waters MD, et al (1981); In Vitro 17,
1004-1 1 1 0.
Inskeep PB, Guengerich FP (1984); Carcinogenesis 2» 805-808.
Isom HC, Secott T, Georgoff 1, et al (1985); Proc. Natl. Acad. 
Sci. 82, 3252-3256.
Jackson BA, Davies JE, Chipman JK (1985); Biochem. Pharmacol. 3 4 , 
3389-3391.
-  111 -
Jacobson M, Levin W, Poppers PJ (1974); Clin. Pharmacol. Ther. 
J_6, 701-710.
Jollow DJ, Mitchell J R , Zampaglione N, et al (1974); Pharmacol. 
II, 151-169.
Jones AD & Spring-Milles E (1977); in Histology 4th ed, Weiss L, 
Creep RO (ed). pp 701.
Jungermann K (1986); Enzyme 3 5 ,  161-180.
Kaplowitz N (1981); Yale J of Med. 54, 497-502.
Karlberg 1 & Lindahl-Kiessling K (1981); Mutat. Res. 8 5 ,
411-416.
Kilworth L, Crane D, Masters C (1984); Biochem. Int. 8, 793-802.
Klebe RJ & Mancuso M (1983); In Vitro J_9, 167- 169.
Kli'german AD & Michalopoulos G ( 1980); Environ. Mutagen _2> 157-
166.
Kluwe W M , McNish R, Smithson K, et al (1981); Biochem. Pharmacol 
30, 2265-2271.
Knight SC, Farrant J, McCann LE (1 977); Cryobiol. J_4, 112-115.
Knowles A F (1982); Biochem. Biophys. Acta. 681, 62-7 1 .
Krack G , Goethals F , Deboyser D, et al (1983); in Isolation, 
Characterisation and Use of Hepatocytes, Harris RA & Cornell NW 
(ed). pp 391-398.
Kusano M, Ebata H, Onishi T, et al (1981); Transplant Proc. 13, 
848-854.
-  112 -
Lafranconi WM, Glatt H, Oesch F (1986); Tox. App. Pharmacol. 8 4 , 
500-511.
Lake BG & Paine A J (1982); Biochem. Pharmacol. 2_1» 2 14 1-2144.
Lau SS & Zannoni VG (1981); J Pharmacol. Exp. Ther. 219,
563-572.
Le Cam A, Guillouzo A, Freychet P ( 1976); Exp. Cell. Res. 98, 
382-395.
Lee LB, Seddon T, Boobis AR, et al ( 1985); Br. J Clin. Pharmacol 
2_9 , 279-294 .
Leibo SP, Farrant J, Mazur P, et al ( 1 970); Cryobiology _6» . 
315-332.
Leibo SP & Mazur P (1971); Cryobiology 8, 447-452.
Lemonnier F , Gautier M, Moatti N, et al (1976); In Vitro 12,
46 0-46 6.
Leningher AL (1970); Biochemistry 2nd ed.
Liddiard C, Merker HJ, Nau H (1980); Arch. Toxicol. 44 ,
107-112. '
LKB Wallac; Data Sheet 507: The bioluminescent assay of ATP and 
ADP in blood components. LBK Wallac, Turku, Finland.
Lopez-Alarcon L, Mofena M, Monge L, et al (1986); Biochem. 
Biophys. Res. Com. 134, 292-298.
Maekubo H, Ozaki S, Mitonaker B, et al (1982); In Vitro 18, 
483-491.
- 1 1 3 -
Maganto P, Cienfuegos JA, Eroles G, et al (1986); Transplant 
Proc. 28, 1224-1229.
Marceau N, Baribault H, Germain L, et al (1986); in Research in 
Isolated and Cultured Hepatocytes, Guillouzo A & Guguen-Guillouzo 
C (ed). pp 39-6 1.
Marselos M, Strom SC, Michalopoulos G (1986); Cell. Biol.
Toxicol. 2, 257-269.
Martelli A, Robbiano L, Ghia M, et al (1986); Cancer Lett. 30 ,
11-16.
Maslanski C J & Williams GM (1982); In Vitro J_8, 683-693.
Michalopoulos G , Russell F , Biles C (1979); In Vitro V 5 , 796-806.
Miller EC (1978); Cancer Res. 22, 1479.
Mitchell AM (1985); PhD Thesis, University of Surrey.
Mitchell DB, Acosta D, Bruckner JV (1985); Toxicology 37,
127-146.
Mitchell JR, Jollow DJ, Potter WZ, et al (1973); J Pharmacol.
Exp. Ther . 187, 211-217.
Miyajima K, Tomita K , Nakagaki M (1986); Chem. Pharmacol. Bull. 
22, 2689-2697.
Miyazaki K, Takaki R, Nakayama F , et al (1981); Cell Tiss. Res. 
218, 13-21.
Miyazaki M, Tsunashima M, Wahid S, et al (1984); J Res. Exp. Med. 
184, 191.
- 1 1 4  -
Miyazki M, Handa Y, Oda M, et al (1985); Exp. Cell Res. 159, 
176-190.
Moldeus P, Grundin R, Vadi H, et al. (1974); Eur. J Biochem. 46, 
351-360.
Moldeus P ( 1 978); Biochem. Pharmacol. _27, 2859-2863.
Moldeus P & Jernstrom B (1983); in Functions of Glutathione; 
Biochemical, Physiological, lexicological and Clinical Aspects, 
Larsson A et al (ed). pp 99-107.
Moller B & Dargel R (1984); Acta. Pharmacol. Toxicol. 55, 
126-132.
Moore CJ & Gould MN (1984); Carcinogenesis 2» 1577-1582.
Morin 0 & Normand C (1 986); J Cell. Physiol. 129, 103- 1 1 1.
Mulder GJ (1984); in Progress in Drug Metabolism, Bridges JW & 
Chasseaud LF (ed), 8 ,  37-87.
Muller L & Ohnesorge FK (1984); Toxicol. 21» 297-306.
Nakamura T & Ichihara A (1985); Cell Structure and Function 10, 
1-16.
Nardone RM (1977); in Growth, Nutrition and Metabolism of Cells 
in Culture, Rothbat GH & Cristofalo VJ (ed). Ill, 
pp 4 71-491.
Nau H, Liddiard C, Merker MD, et al (1978); Life Soi 23 , 
2361-2372.
Novicki DL, Irons GP, Strom SC, et al (1982); In Vitro J2» 393- 
399.
- 1 1 5 -
Nutt L H , Attenburrow VD, Fuller BJ ( 1980); Cryo. Letters J_, 5 13-
518.
Omura T & Sato R (1964); J Biol. Chem. 239, 2370-2379.
Paine AJ & Hocki n LJ (1980); Biochem. Pharmacol. 22» 3215-3218.
Paine AJ & Villa P (1980); Biochem. Biophys. Res. Comm. 97, 
744-750.
Paine AJ, Villa P, Hockin LJ (1980); Biochem. J J_88, 937-939 .
Paine AJ, Hockin LJ, Allen CM (1 982); Biochem. Pharmacol. 31 ,
1175-1178.
Parker VH (1952); Biochem. J 5JI, 363-370.
Patsch W, Gotto AM, Patsch JR (1 986); J Biol. Chem. 261 ,
9603-9607.
Pelkonen 0, Korhonen P, Jouppila P, et al (1975); Life Soi. 16,
14 03-1410.
Porter WR, Gudzinowicz MJ, Neal RA (1979); J Pharmacol. Exp.
Ther. 208, 386-391 .
Porubek DJ, Rundgren M, Harrison PJ, et al (1987); Mol..
Pharmacol. 21 » 647.
Quistorff B, Dich J, Grunnet N (1986); Biochem. Biophys. Res.
Com. 229, 1055-1062.
Rao ML, Rao GS, Holler M, et al (1976); H o ppe S e y l e r ’s Z Physiol 
Chem. 357» 573-584.
Rappaport AM (1979a); in Diseases of the Liver, 3rd edition, 
Schiff L (ed). pp 1.
-  116 -
Rappaport AM (1979b); in Toxic Injury of the Liver (Part A), 
Farber E & Fisher MM (ed). pp 1.
Ratanasavanh D, Beaune P, Baffet G, et al (1986); J Histochem. & 
Cytochem. 22» 527-533.
Recknagel RO & Glende EA (1973); CRC Grit. Rev. Toxicol. 2, 263.
Reed DJ, Brodie AN, Meredith MJ (1983); in Functions of 
Glutathione: Biochemical, Physiological and Clinical Aspects. 
Larsson et al (ed). pp 39-49.
Reese JA & Byard JL (1981); In Vitro JJ, 935-940.
Reid LM & Jefferson DM (1984); Hepatology _4» 548-559.
Reid LM, Narita M, Fufita M, et al (1986); in Research in 
Isolated and Cultured Hepatocytes, Guillouzo A & Guguen-Guillouzo 
C (ed). pp 225-258.
Reid WD, Christie B. Eichelbaum M, et al (1971); Exp. Mol..
Pathol. 22 363-372.
Reid WD & Krishna G (1973); Exp. Mol. Pathol. 22, 80-99.
Rheinhardt CA & Pelli DA (1986); F d . Chem. Tox. 21» 576.
Rickwood D (1983); in lodinated Density Gradient Media, Rickwood 
D (ed). pp 1-14.
Rikans LE, Hornbrook KR (1986); Tox. Appl. Pharmacol. 8 4 ,
634-639.
Robbiano L, Gazzaniga GM, Martelli A, et al (1986); Mutat. Res. 
173, 229-232.
Sandstom B (1973); Acta Hepatogastroenterol 20, 19-23.
-  1 1 7 -
Saville B (1958); Analyst 83, 670-672.
Schuetz EG, Wrighton A, Safe S H , et al (1986); Biochem. 22, 1124-
1133.
Seddon T, Oldham HG, Kirby R, et al (1986); 10th European 
Workshop on Drug Metabolism at University of Surrey.
Seglen PC ( 1976a); Methods in Cell Biol. J_3 , 29-83.
Seglen PC (197,6b); Biochem. Biophys. Acta 442, 391 .
Shih TW & Hill DL (1981); Res. Comm. Chem. Path. Pharmacol. 33, 
449-459.
Silove M & Hattingh J (1986); Gen. Pharmacol. J J _ , 191-196.
Slater TF (1978); in Biochemical Mechanisms of Liver Injury, 
Slater TF (ed). pp 1-44.
Smith AJ & Chipman JK (1986); 10th European Workshop on Drug 
Metabolism at University of Surrey.
Soboll S, Aberboum TP, Schwenke W D , et al (1980); Biochem. J 192, 
951-954.
Steward A R , Dannan GA, Guzelian PS, et al (1985); Mol. Pharmacol. 
27, 125-132.
Stoner GD (1980); in Methods in Cell. Biol., Harris CC (ed).
21 A pp 65-77.
Storer RD & Connolly RB (1983); Carcinogenesis 4_> 1 491 -1 494.
Strom SC, Jirtle RL, Jones RS, et al (1982); JNCl 22» 771-778.
- 118 -
Strom SC, Jirtle RL, Michalopoulos G (1983a); Environ. Health. 
Persp. 4_9 » 165- 1 70.
Strom SC, Novicki DL, Novotny A, et al (1983b); Carcinogenesis 2» 
683-686.
Sundheimer DW, White RD, Brendel K (1982); Carcinogenesis _3, 
1129-1133.
Suolinna EM, Sjoholm AC, Saarento M (1986); 10th European 
Workshop on Drug Metabolism at University of Surrey.
Sweeney GD (1981); Trends in Pharmacol. Sci. 2 ,  14 1-144.
Tee LBG, Seddon T, Boobis AR, et al (1985); B r . J Clin.
Pharmacol. 2_9, 2 79-294 .
Thor H, Moldeus P, Kristoferson A, et al (1978); Arch, of 
Biochem. & Biophys. 188, 114-121.
Thor H, Moldeus P, Orrenius S (1979); Arch. Biochem. Biophys.
192, 405-413.
Thor H & Orrenius S (1 980); Arch. Toxicol. 4_4, 31-43.
Timbrell JA ( 1 983); B r . J Clin. Chem. J_5» 3-14.
Timbrell JA (1986); in Target Organ Toxicity, Cohen GM (ed).
2, pp 145-169 .
Tisquaye KN (1978); Br. J Exp. Pathol. 22» 482-488.
Trennery PN & Waring RM (1 983); Toxicol. Lett. J_9 , 299-307 .
Trump BE, Resau J, Barrett LA (1980); Methods in Cell Biol. 21A , 
1-14.
-  119 -
Van Bladeren PJ, Breiraer DD, Van Huijgevoort et al (1981a); 
Biochem. Pharmacol. 22» 2499-2502.
Van Bladeren PJ, Hoogeterp J J , Breimer DD et al (1981b); Biochem 
Pharmacol. 30, 2983-2987.
Vandenberge Y, Ratanasavanh D, Guillouzo A (1986); 10th European 
Workshop on Drug Metabolism at University of Surrey.
Van de Straat R, De Vries J, Kulkens J, et al (1986); Biochem. 
Pharmacol. 35, 3693-3699.
Villa-Trevino S, Schull KH, Farber E (1964); J Biol. Chem. 238, 
1757-1763.
Vonen B & Moorland J (1984); Arch. Toxicol. _52» 33-37.
Warren M, Fry J R , Balls M (1 985); Xenobiotica J_5, 775-780.
Wendel A, Feuerstein S, Honz K-H (1979); Acta. Pharmacol. 
Toxicol. 22»
Weibkin P, Parker GL, Fry JR, et al (1979); Biochem. Pharmacol. 
28, 3315-3321.
Wildenauer OB & Oehlmann GE ( 1 982); Biochem. Pharmacol. 31 , 
3535-354 1 .
Williams GM (1976); Cancer Lett. J_, 231-236.
Wirthensohn K & Barth CA ( 1985); In Vitro _2I> 546-553.
Zimmerman HJ. (1978); Hepatology; The adverse effect of drugs and 
other chemicals on the liver.
